<SEC-DOCUMENT>0001140361-23-038901.txt : 20230810
<SEC-HEADER>0001140361-23-038901.hdr.sgml : 20230810
<ACCEPTANCE-DATETIME>20230810071716
ACCESSION NUMBER:		0001140361-23-038901
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230810
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230810
DATE AS OF CHANGE:		20230810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Coeur Mining, Inc.
		CENTRAL INDEX KEY:			0000215466
		STANDARD INDUSTRIAL CLASSIFICATION:	GOLD & SILVER ORES [1040]
		IRS NUMBER:				820109423
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-08641
		FILM NUMBER:		231157171

	BUSINESS ADDRESS:	
		STREET 1:		200 SOUTH WACKER DRIVE
		STREET 2:		SUITE 2100
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606
		BUSINESS PHONE:		312-489-5800

	MAIL ADDRESS:	
		STREET 1:		200 SOUTH WACKER DRIVE
		STREET 2:		SUITE 2100
		CITY:			CHICAGO
		STATE:			IL
		ZIP:			60606

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	COEUR D ALENE MINES CORP
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ny20009915x2_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:cde="http://coeur.com/20230810" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font: 10pt Times New Roman, Times, Serif">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_e6db019fd2d64d97b8bfc49b21e545df" contextRef="c20230810to20230810" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_2b052ea68b63457686f924a8e48bac30" contextRef="c20230810to20230810">0000215466</ix:nonNumeric><ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_9af5b99b7b1f4429bac9d9bd68173640" contextRef="c20230810to20230810">IL</ix:nonNumeric><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_7b510316653e4b78a46dfb8577bc842b" contextRef="c20230810to20230810">NYSE</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="cde-20230810.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20230810to20230810"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000215466</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-08-10</xbrli:startDate><xbrli:endDate>2023-08-10</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>
  <!-- Field: Rule-Page -->
  <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
  <!-- Field: /Rule-Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>UNITED STATES</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES AND EXCHANGE COMMISSION</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Washington, D.C. 20549</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  <p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>
  <!-- Field: Rule-Page -->
  <div style="margin: 3pt auto; width: 25%">
    <div style="font-size: 1pt; border-top: Black 1pt solid">&#160;</div>

  </div>

  <!-- Field: /Rule-Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>
  <p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>
  <p style="font: 18pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_a5038d14aba746a69227ec7c4fa533ca" contextRef="c20230810to20230810">8-K</ix:nonNumeric></b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>CURRENT REPORT PURSUANT</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>TO SECTION 13 OR 15 (d) OF THE</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SECURITIES EXCHANGE ACT OF 1934</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Date of report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_c05f01a1b8484fe1a2717d790a8a1919" contextRef="c20230810to20230810" format="ixt:date-monthname-day-year-en">August 10, 2023</ix:nonNumeric></b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <p style="font: 24pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_74cb38877efc449e8780f6c38ec5cf14" contextRef="c20230810to20230810">Coeur Mining, Inc.</ix:nonNumeric></span><br />
  </p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>(Exact name of registrant as specified in its charter)</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">


  <tr style="vertical-align: top">

    <td style="width: 33%; text-align: center;"><b><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_fbd0bc66b0724329b29d5cc8041e0df3" contextRef="c20230810to20230810" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
          </b></td>

    <td style="width: 34%; text-align: center;"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_514fee11664a4c62ba7e6f9a44b7511e" contextRef="c20230810to20230810">1-8641</ix:nonNumeric></span><br />
        </td>

    <td style="width: 33%; text-align: center"><span style="font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_d8bf0e27240546b9b7227f1346c43e1a" contextRef="c20230810to20230810">82-0109423</ix:nonNumeric></span><br />
        </td>

  </tr>

  <tr style="vertical-align: top">

    <td style="text-align: center; width: 33%;">(State or other jurisdiction of incorporation)</td>

    <td style="text-align: center; width: 34%;">(Commission File Number)</td>

    <td style="text-align: center; width: 33%;">(I.R.S. Employer Identification No.)</td>

  </tr>


</table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">


  <tr>

    <td style="vertical-align: top; width: 81%; text-align: center"><b><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_0506c8148dd64432b535746b66722451" contextRef="c20230810to20230810">200 S. Wacker Dr.</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_8016f7cf98da4123a97ac0a13dd02201" contextRef="c20230810to20230810">Suite 2100</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_14537aa7d57a4bf48dc06b4f9c3e8700" contextRef="c20230810to20230810">Chicago</ix:nonNumeric>, <span style="-sec-ix-hidden:Fact_9af5b99b7b1f4429bac9d9bd68173640">IL</span></b></td>

    <td style="vertical-align: bottom; width: 19%; text-align: center; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_56722a93eaf24425a1610648fdedbef6" contextRef="c20230810to20230810">60606</ix:nonNumeric></td>

  </tr>

  <tr style="vertical-align: top">

    <td style="text-align: center">(Address of principal executive offices)</td>

    <td style="text-align: center">(Zip Code)</td>

  </tr>


</table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Registrant&#8217;s telephone number, including area code:&#160; (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_f663b8e6f0e140d7b9b7b1a38b42ec85" contextRef="c20230810to20230810">312</ix:nonNumeric>)
      <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_e2a16f29de8a4557be3a0781277fbc0d" contextRef="c20230810to20230810">489-5800</ix:nonNumeric></b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">


  <tr style="vertical-align: top">

    <td style="width: 2%;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_cc2dc65aa9274ca1952419e9b13db0b3" contextRef="c20230810to20230810" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
        </td>

    <td style="width: 98%;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</td>

  </tr>


</table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">


  <tr style="vertical-align: top">

    <td style="width: 2%;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_69be07e03ac14a1d9897bebe18af765f" contextRef="c20230810to20230810" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
        </td>

    <td style="width: 98%;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</td>

  </tr>


</table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">


  <tr style="vertical-align: top">

    <td style="width: 2%;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_04074b7eb0e346b699d1231af3bbf1dd" contextRef="c20230810to20230810" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
        </td>

    <td style="width: 98%;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</td>

  </tr>


</table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">


  <tr style="vertical-align: top">

    <td style="width: 2%;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_bf86179f659c40df93601320a1e43fd9" contextRef="c20230810to20230810" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
        </td>

    <td style="width: 98%;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</td>

  </tr>


</table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">


  <tr style="vertical-align: top">

    <td style="border-bottom: 1pt solid Black; white-space: nowrap; width: 33%; text-align: center;">Title of each class</td>

    <td style="padding-bottom: 1pt; white-space: nowrap; width: 1%;">&#160;</td>

    <td style="border-bottom: 1pt solid Black; white-space: nowrap; width: 32%; text-align: center;">Trading Symbol(s)</td>

    <td style="padding-bottom: 1pt; white-space: nowrap; width: 1%;">&#160;</td>

    <td style="border-bottom: 1pt solid Black; white-space: nowrap; width: 33%; text-align: center;">Name of each exchange on which registered</td>

  </tr>

  <tr style="vertical-align: top">

    <td style="text-align: center; width: 33%;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_8d3532629e774a63aafb91f15f1164aa" contextRef="c20230810to20230810">Common Stock (par value $.01 per share)</ix:nonNumeric><br />
        </td>

    <td style="width: 1%;">&#160;</td>

    <td style="text-align: center; width: 32%;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_e7c6fe8ec0e1495ca78feac2fde7fade" contextRef="c20230810to20230810">CDE</ix:nonNumeric><br />
        </td>

    <td style="width: 1%;">&#160;</td>

    <td style="text-align: center; width: 33%;"><span style="-sec-ix-hidden:Fact_7b510316653e4b78a46dfb8577bc842b">New York Stock Exchange</span><br />
        </td>

  </tr>


</table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
    Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right; text-indent: 0.5in">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_d0db397d7d794693a0d39de2c2afc40c" contextRef="c20230810to20230810" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
    standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#160;&#160; &#9744;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>
  <!-- Field: Rule-Page -->
  <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

  </div>

  <!-- Field: Page; Sequence: 1 -->
  <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt">
    <p style="margin: 0pt">&#160;</p>
  </div>

  <!-- Field: /Page -->
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">


  <tr style="vertical-align: top">

    <td style="width: 1in"><b>Item 8.01.</b></td>

    <td><b>Other Events.</b></td>

  </tr>


</table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">Each of the ATM Equity Offering Sales Agreement, dated as of August 10, 2023, among Coeur Mining, Inc. and BMO Capital Markets Corp., RBC Capital
    Markets, LLC and BofA Securities, Inc., which is filed as Exhibit 1.1 of this Current Report on Form 8-K, and the opinion of Gibson, Dunn &amp; Crutcher LLP, which is filed as Exhibit 5.1 to this Current Report on Form 8-K, is incorporated herein by
    reference. The opinion was issued in connection with the filing of the prospectus supplement on Form 424(b)(5), filed with the U.S. Securities and Exchange Commission on equal date herewith, forming part of the registration statement (File No.
    333-262799).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">


  <tr style="vertical-align: top">

    <td style="width: 1in"><b>Item 9.01.</b></td>

    <td><b>Financial Statements and Exhibits.</b></td>

  </tr>


</table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">List of Exhibits</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">


  <tr>

    <td style="vertical-align: top; width: 8%; border-bottom: Black 1pt solid; text-align: justify">
          <p style="margin-top: 0; margin-bottom: 0"><b>Exhibit</b></p>
          <p style="margin-top: 0; margin-bottom: 0"><b>No.</b></p>
        </td>

    <td style="vertical-align: top; width: 1%">&#160;</td>

    <td style="vertical-align: bottom; width: 91%; border-bottom: Black 1pt solid"><b>Description</b></td>

  </tr>

  <tr style="vertical-align: top; background-color: rgb(204,238,255)">

    <td style="text-align: center"><a style="-sec-extract: exhibit" href="ny20009915x2_ex1-1.htm">1.1</a></td>

    <td>&#160;</td>

    <td><a style="-sec-extract: exhibit" href="ny20009915x2_ex1-1.htm">ATM Equity Offering Sales Agreement, dated as of August 10, 2023, among Coeur Mining, Inc.
            and BMO Capital Markets Corp., RBC Capital Markets, LLC and BofA Securities, Inc.</a></td>

  </tr>

  <tr style="vertical-align: top; background-color: White">

    <td style="text-align: center"><a style="-sec-extract: exhibit" href="ny20009915x2_ex5-1.htm">5.1</a></td>

    <td>&#160;</td>

    <td><a style="-sec-extract: exhibit" href="ny20009915x2_ex5-1.htm">Opinion of Gibson, Dunn &amp; Crutcher LLP.</a></td>

  </tr>

  <tr style="vertical-align: top; background-color: rgb(204,238,255)">

    <td style="text-align: center"><a style="-sec-extract: exhibit" href="ny20009915x2_ex5-1.htm">23.1</a></td>

    <td>&#160;</td>

    <td><a style="-sec-extract: exhibit" href="ny20009915x2_ex5-1.htm">Consent of Gibson, Dunn &amp; Crutcher LLP (included in its opinion filed as Exhibit 5.1).</a></td>

  </tr>

  <tr style="vertical-align: top; background-color: White">

    <td style="text-align: center">104</td>

    <td>&#160;</td>

    <td>Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.</td>

  </tr>


</table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p>
  <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
    <div style="page-break-after: always;" class="BRPFPageBreak">
      <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

  </div>

  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>SIGNATURE</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly
    authorized.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">


  <tr style="vertical-align: top">

    <td>&#160;</td>

    <td colspan="2">COEUR MINING, INC.</td>

  </tr>

  <tr style="vertical-align: top">

    <td style="width: 50%">&#160;</td>

    <td style="width: 5%">&#160;</td>

    <td style="width: 45%">&#160;</td>

  </tr>

  <tr style="vertical-align: top">

    <td>&#160;</td>

    <td>By:</td>

    <td style="border-bottom: Black 1pt solid">/s/ Thomas S. Whelan</td>

  </tr>

  <tr style="vertical-align: top">

    <td>&#160;</td>

    <td>Name:</td>

    <td>Thomas S. Whelan</td>

  </tr>

  <tr style="vertical-align: top">

    <td>&#160;</td>

    <td>Title:</td>

    <td>Senior Vice President and Chief Financial Officer</td>

  </tr>


</table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">DATED:&#160; August 10, 2023</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>
  <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" />
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
  <!-- Field: Page; Sequence: 3; Options: Last -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ny20009915x2_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  <!-- Field: Rule-Page -->
  <div style="margin: 0 auto; width: 100%">
    <div style="font-size: 1pt; border-top: Black 4pt solid">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><b>&#160;</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: right"><b>Exhibit 1.1</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>COEUR MINING, INC.</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">$50,000,000 Shares of<br>
    Common Stock<br>
    ($0.01 Par Value Per Share)</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ATM EQUITY OFFERING<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">SM</sup> SALES AGREEMENT</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">August 10, 2023</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BMO Capital Markets Corp.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">151 W 42nd Street</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10036</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RBC Capital Markets, LLC</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">200 Vesey Street, 8th Floor</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brookfield Place New York</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10281</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BofA Securities, Inc.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">One Bryant Park</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">New York, New York 10036</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Ladies and Gentlemen:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Coeur Mining, Inc., a Delaware corporation (the &#8220;<b>Company</b>&#8221;), confirms its agreement (this &#8220;<b>Agreement</b>&#8221;) with BMO Capital Markets Corp. (the &#8220;<b>BMO</b>&#8221;),
    RBC Capital Markets, LLC (&#8220;<b>RBC</b>&#8221;) and BofA Securities, Inc. (&#8220;<b>BofA</b>,&#8221; and together with BMO and RBC, the &#8220;<b>Agents</b>&#8221; and each individually, an &#8220;<b>Agent</b>&#8221;) with respect to the issuance and sale from time to time by the Company of
    shares (the &#8220;<b>Shares</b>&#8221;) of the Company&#8217;s common stock, $0.01 par value per share (the &#8220;<b>Common Stock</b>&#8221;), having an aggregate offering price of up to <b>Fifty Million United States Dollars ($50,000,000)</b> (the &#8220;<b>Maximum Amount</b>&#8221;)
    through or to the Agents, as sales agents or principals, on the terms and subject to the conditions set forth in this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company has prepared and filed with the Securities and Exchange Commission (the &#8220;<b>Commission</b>&#8221;) an &#8220;automatic shelf registration statement,&#8221; as defined under
    Rule 405 (&#8220;<b>Rule 405</b>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<b>Act</b>&#8221;), on Form S-3 (Registration No. 333-262799) covering the public offering and sale of certain securities of the Company, including the Shares (the &#8220;<b>registration



      statement</b>&#8221;), under the Act and the rules and regulations of the Commission thereunder (collectively, the &#8220;<b>Rules and Regulations</b>&#8221;). The Registration Statement (as defined below) sets forth the material terms of the offering, sale and plan
    of distribution of the Shares and contains additional information concerning the Company and its business. Except where the context otherwise requires, the term &#8220;<b>Registration Statement</b>&#8221; means the registration statement, as amended by any
    post-effective amendments thereto at the time of the registration statement&#8217;s effectiveness for purposes of Section 11 of the Act, as such section applies to each Agent, as well as any new registration statement or post-effective amendment as may have
    been filed pursuant to Section 3(h) or (i) of this Agreement, including (i) the exhibits and any schedules thereto and all documents filed as a part thereof or incorporated, or deemed to be incorporated, by reference therein pursuant to Item 12 of Form
    S-3 under the Act at such time and (ii) any information or documents contained or incorporated by reference in a prospectus filed with the Commission pursuant to Rule 424(b) of the Rules and Regulations, to the extent such information is deemed,
    pursuant to Rule 430B or Rule 430C of the Rules and Regulations, to be part of the registration statement at the effective time. Except where the context requires, the term &#8220;<b>Base Prospectus</b>&#8221; means the prospectus filed as part of the Registration
    Statement, as amended in the form in which it has been filed most recently with the Commission, including the documents incorporated or deemed incorporated by reference therein pursuant to Item 12 of Form S-3 under the Act. Except where the context
    otherwise requires, the term &#8220;<b>Prospectus Supplement</b>&#8221; means the most recent prospectus supplement relating to the Shares, to be prepared and filed by the Company with the Commission pursuant to Rule 424(b) of the Rules and Regulations on or
    before the second business day after the date hereof (or such earlier time as may be required under the Act or agreed to by the Company and each Agent), in the form furnished by the Company to the Agents in connection with the offering of the Shares,
    including the documents incorporated or deemed to be incorporated by reference therein pursuant to Item 12 of Form S-3 under the Act. Except where the context otherwise requires, the term &#8220;<b>Prospectus</b>&#8221; means the Prospectus Supplement (and any
    additional prospectus supplement prepared in accordance with the last sentence of Section 3(cc) and filed in accordance with the provisions of Rule 424(b) of the Rules and Regulations), together with the Base Prospectus attached to or used with the
    Prospectus Supplement. &#8220;<b>Permitted Free Writing Prospectus</b>&#8221; has the meaning set forth in Section 3(g). Any reference herein to the Registration Statement, the Base Prospectus, the Prospectus Supplement, the Prospectus and any Permitted Free
    Writing Prospectus shall, unless otherwise stated, be deemed to refer to and include the documents, if any, incorporated, or deemed to be incorporated, by reference therein (the &#8220;<b>Incorporated Documents</b>&#8221;), including, unless the context otherwise
    requires, the documents, if any, filed as exhibits to such Incorporated Documents. Any reference herein to the terms &#8220;<b>amend</b>,&#8221; &#8220;<b>amendment</b>&#8221; or &#8220;<b>supplement</b>&#8221; with respect to the Registration Statement, the Base Prospectus, the
    Prospectus Supplement, the Prospectus or any Permitted Free Writing Prospectus shall, unless stated otherwise, be deemed to refer to and include the filing of any document under the Securities Exchange Act of 1934, as amended, and the rules and
    regulations of the Commission thereunder (collectively, the &#8220;<b>Exchange Act</b>&#8221;) on or after the initial effective date of the Registration Statement or the date of the Base Prospectus, the Prospectus Supplement, the Prospectus or such Permitted Free
    Writing Prospectus, as the case may be, and deemed to be incorporated therein by reference. For purposes of this Agreement, all references to the Registration Statement, the Base Prospectus, the Prospectus Supplement, the Prospectus or any Permitted
    Free Writing Prospectus or any amendment or supplement thereto shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval system (or any successor system) (&#8220;<b>EDGAR</b>&#8221;).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>
  <!-- Field: Page; Sequence: 1; Options: NewSection; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Company confirms its agreement with each Agent as follows:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Sale and Delivery of the Shares.</u></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Agency Transactions.</i> On the basis of the representations, warranties and agreements herein contained, but subject to the terms and conditions herein
    set forth, the Company and each of the Agents agree that the Company may issue and sell the Shares through an Agent, as sales agent for the Company for the purpose of soliciting purchases of the Shares from the Company pursuant to this Agreement (an &#8220;<b>Agency



      Transaction</b>&#8221;) as follows:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company may, from time to time, propose to an Agent determined in the sole discretion of the Company (the &#8220;<b>Designated Agent</b>&#8221;) the terms of an
    Agency Transaction by means of a written notice or by a telephone call (confirmed promptly by electronic mail in a form substantially similar to <b><u>Exhibit A</u></b> hereto (an &#8220;<b>Agency Transaction Notice</b>&#8221;)) from any of the individuals listed
    as authorized representatives of the Company on <b><u>Schedule 1</u></b> hereto (each, an &#8220;<b>Authorized Company Representative</b>&#8221;), such proposal to include: the trading day(s) for the New York Stock Exchange (the &#8220;<b>Exchange</b>&#8221;) (which may not
    <font style="font-family: Times New Roman, Times, Serif">be a day on which the Exchange is scheduled to close prior to its regular weekday closing time) on which the Shares are to be sold (each, a &#8220;<b>Trading Day</b>&#8221;); the maximum number of Shares
      that the Company wishes to sell in the aggregate and on each Trading Day (the &#8220;<b>Placement Shares</b>&#8221;); and the minimum price at which the Company is willing to sell the Shares (the &#8220;<b>Floor Price</b>&#8221;).</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt"><font style="font-family: Times New Roman, Times, Serif">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If such proposed terms for an Agency Transaction are acceptable to the Designated Agent, it shall
      promptly confirm the terms by countersigning the Agency Transaction Notice for such Agency Transaction and emailing it to an Authorized Company Representative. The Agency Transaction Notice shall be effective unless and until (i) the Designated
      Agent, in accordance with the notice requirements set forth in Section 1(a)(iv) below, suspends or terminates the Agency Transaction Notice for any reason, in its sole discretion, (ii) the entire amount of the Placement Shares have been sold, (iii)
      in accordance with the notice requirements set forth in Section 1(a)(iv) below, the Company suspends or terminates the Agency Transaction Notice for any reason, in its sole discretion, (iv) the Company issues a subsequent Agency Transaction Notice
      with parameters superseding those on the earlier dated Agency Transaction Notice, or (v) this Agreement has been terminated under the provisions of Section 6.</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt"><font style="font-family: Times New Roman, Times, Serif">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subject to the terms and conditions hereof, each Designated Agent shall use its commercially
      reasonable efforts, consistent with its normal trading and sales practices and applicable law and regulations, to sell all of the Shares designated in, and subject to the terms of, such Agency Transaction Notice. No Designated Agent shall sell any
      Share at a price lower than the Floor Price. The Company acknowledges and agrees with each Designated Agent that (x) there can be no assurance that the Designated Agent will be successful in selling all or any of such Shares, (y) the Designated Agent
      shall incur no liability or obligation to the Company or any other person or entity if it does not sell any Shares for any reason and (z) the Designated Agent shall be under no obligation to purchase any Shares on a principal basis pursuant to this
      Agreement (except in the case of a Principal Transaction (as defined below) pursuant to this Agreement and the relevant Terms Agreement (as defined below)).</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company, acting through an Authorized Company Representative, or the applicable Designated Agent under the Agency Transaction Notice may, upon notice to
    the other party hereto by writing or by telephone (confirmed promptly by electronic mail), suspend an offering of the Shares for any reason and at any time; <i>provided</i>, <i>however</i>, that such suspension shall not affect or impair the parties&#8217;
    respective obligations with respect to the Shares sold hereunder prior to the giving of such notice.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;If the terms of any Agency Transaction as set forth in an Agency Transaction Notice contemplate that the Shares shall be sold on more than one Trading Day,
    then the Company and the Designated Agent shall mutually agree to such additional terms and conditions as they deem necessary in respect of such multiple Trading Days, and such additional terms and conditions shall be binding to the same extent as any
    other terms contained in the relevant Agency Transaction Notice.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Each Agent, as a sales agent in an Agency Transaction, shall not make any sales of the Shares on behalf of the Company, pursuant to this Agreement, other
    than (x) by means of ordinary brokers&#8217; transactions that qualify for delivery of the Prospectus in accordance with Rule 153 of the Rules and Regulations and meet the definition of an &#8220;at the market offering&#8221; under Rule 415(a)(4) of the Rules and
    Regulations and (y) such other sales of the Shares on behalf of the Company in its capacity as agent of the Company as shall be agreed by the Company and the Agent in writing.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;The compensation to a Designated Agent for sales of the Shares in an Agency Transaction with respect to which such Designated Agent acts as sales agent
    hereunder shall be up to 1.5% of the gross sales price per Share sold through such Designated Agent. The Designated Agent shall provide written confirmation to the Company (which may be provided by email to an Authorized Company Representative)
    following the close of trading on the Exchange on each Trading Day on which Shares are sold in an Agency Transaction under this Agreement, setting forth (i) the number of Shares sold on such Trading Day, (ii) the gross offering proceeds received from
    such sales, (iii) the commission payable by the Company to the Designated Agent with respect to such sales and (iv) the net offering proceeds (being the gross offering proceeds for such sales less the commission payable for such sales and less any
    transaction fees, transfer taxes or similar taxes or fees imposed by any governmental entity or self-regulatory organization in respect of such sales) (the &#8220;<b>Net Offering Proceeds</b>&#8221;).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(viii)&#160;&#160;&#160;&#160;&#160;&#160;Settlement for sales of the Shares in an Agency Transaction pursuant to this Agreement shall occur on the second (2<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup>) Trading Day (or such earlier day as is industry practice for regular-way trading) following the date on which such sales are made (each such day, an &#8220;<b>Agency Settlement Date</b>&#8221;). On each Agency
    Settlement Date, the Shares sold through the Designated Agent in Agency Transactions for settlement on such date shall be issued and delivered by the Company to such Designated Agent against payment by such Designated Agent to the Company of the Net
    Offering Proceeds from the sale of such Shares. Settlement for all such Shares shall be effected by free delivery of the Shares by the Company or its transfer agent to the Designated Agent&#8217;s or its designee&#8217;s account (<i>provided</i> that the
    Designated Agent shall have given the Company written notice of such designee prior to the relevant Agency Settlement Date) at The Depository Trust Company or by such other means of delivery as may be mutually agreed upon by the parties hereto, which
    in all cases shall be freely tradable, transferable, registered shares in good deliverable form, in return for payment in same-day funds delivered to the account designated by the Company. If the Company, or its transfer agent (if applicable), shall
    default on its obligation to deliver the Shares on any Agency Settlement Date, the Company shall (i) indemnify and hold the Designated Agent harmless against any loss, claim, damage, or expense (including, without limitation, reasonable legal fees and
    expenses), as incurred, arising out of or in connection with such default by the Company and (ii) pay the Designated Agent any commission, discount or other compensation to which it would otherwise be entitled absent such default.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 3; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Principal Transactions.</i> If the Company wishes to issue and sell the Shares other than as set forth in subsection (a) of this Section 1 (each, a &#8220;<b>Principal


      Transaction</b>&#8221;), the Company will notify the Agents of the proposed terms of such Principal Transaction. If any Agent, acting as principal, wishes to accept such proposed terms (which it may decline to do for any reason in its sole discretion) or,
    following discussions with the Company, wishes to accept amended terms, the Agent(s) and the Company will enter into an agreement in substantially the form of <b><u>Exhibit B</u></b> hereto (each, a &#8220;<b>Terms Agreement</b>&#8221;) that sets forth the terms
    of such Principal Transaction, including, without limitation, the time, date and place of delivery of and payment for the Shares to be sold pursuant to such Principal Transaction (each of such date and each Agency Settlement Date, a &#8220;<b>Settlement Date</b>&#8221;).


    The terms set forth in a Terms Agreement shall not be binding on the Company or the Agent(s) unless and until each of the Company and the applicable Agent(s) has executed such Terms Agreement accepting all of such terms. The commitment of the
    applicable Agent(s) to purchase the Shares pursuant to any Terms Agreement shall be deemed to have been made on the basis of the representations and warranties of the Company herein contained and shall be subject to the terms and conditions herein set
    forth. In the event of a conflict between the terms of this Agreement and the terms of any Terms Agreement, the terms of such Terms Agreement shall control.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Maximum Number of Shares.</i> Under no circumstances shall the Company propose to any Agent, or any Agent effect, a sale of Shares in an Agency
    Transaction or a Principal Transaction pursuant to this Agreement if such sale would (i) cause the aggregate gross sales proceeds of the Shares sold pursuant to this Agreement to exceed the Maximum Amount, (ii) cause the number of Shares sold to exceed
    the number of shares of Common Stock available for offer and sale under the then effective Registration Statement or (iii) cause the number of Shares sold pursuant to this Agreement to exceed the number of Shares authorized from time to time to be
    issued and sold pursuant to this Agreement by the Company&#8217;s board of directors, or a duly authorized committee thereof, or approved for listing on the Exchange and, in each case referred to in (ii) and (iii), notified to the Agents in writing. In
    addition, under no circumstances shall the Company propose to any Agent, or any Agent effect, a sale of Shares in an Agency Transaction or a Principal Transaction pursuant to this Agreement at a price lower than the minimum price therefor duly
    authorized from time to time by the Company and notified to the Agents in writing. The Agents shall have no responsibility for maintaining records with respect to Shares available for sale under the Registration Statement or for determining the
    aggregate gross sales price, number or minimum price of Shares duly authorized by the Company.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Regulation M.</i> If either party hereto has reason to believe that the exemptive provisions set forth in Rule 101(c)(1) of Regulation M under the
    Exchange Act are not satisfied with respect to the Company or the Shares, it shall promptly notify the other party and sales of Shares under this Agreement shall be suspended until that or other exemptive provisions have been satisfied in the judgment
    of each party hereto.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Material Information.</i> Notwithstanding any other provision of this Agreement, no sales of Shares shall take place, the Company shall not request the
    sales of any Shares that would be sold and no Agent shall be obligated to sell or offer to sell any Shares during any period in which the Company is, or could be deemed to be, in possession of material non-public information with respect to the
    Company.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Continuing Accuracy of Representations and Warranties.</i> Any obligation of a Designated Agent to use its commercially reasonable efforts to sell the
    Shares on behalf of the Company as sales agent shall be subject to the continuing accuracy of the representations and warranties of the Company herein, to the performance by the Company of its obligations hereunder and to the continuing satisfaction of
    the conditions specified in Section 4 of this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">2.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Representations and Warranties of the Company</u>. The Company represents and warrants to, and covenants with, each Agent as follows:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Effectiveness of Registration.</i> The Registration Statement and any post-effective amendment thereto have become effective. The Company has responded
    to all requests, if any, of the Commission for additional or supplemental information. No stop order suspending the effectiveness of the Registration Statement is in effect and no proceedings for such purpose have been instituted or are pending or, to
    the knowledge of the Company, are contemplated or threatened by the Commission. (i) At the time of filing the Registration Statement, (ii)&#160;at the time of the most recent amendment thereto for purposes of complying with Section&#160;10(a)(3) of the Act
    (whether such amendment was by post-effective amendment, incorporated report filed pursuant to Section&#160;13 or&#160;15(d) of the Exchange Act or form of prospectus) and (iii) at the time the Company or any person acting on its behalf (within the meaning, for
    this clause only, of Rule&#160;163(c) of the Rules and Regulations) made any offer relating to the Shares in reliance on the exemption of Rule&#160;163 of the Rules and Regulations, the Company was and is a &#8220;well-known seasoned issuer&#8221; as defined in Rule&#160;405 of
    the Rules and Regulations. The Registration Statement is an &#8220;automatic shelf registration statement,&#8221; as defined in Rule&#160;405 of the Rules and Regulations, and the Shares, since their registration on the Registration Statement, have been and remain
    eligible for registration by the Company on such Registration Statement. The Company has not received from the Commission any notice pursuant to Rule 401(g)(2) of the Rules and Regulations objecting to use of the automatic shelf registration statement
    form and the Company has not otherwise ceased to be eligible to offer and sell the Shares using the Registration Statement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 4; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Accuracy of the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus.</i> (i) At the respective times the Registration
    Statement and any post-effective amendment thereto became effective, (ii) at each deemed effective date with respect to an Agent pursuant to Rule 430B(f)(2) under the Act, (iii) as of each Time of Sale (as defined below), (iv) at each Settlement Date
    and (v) at all times during such period as the Prospectus is required by law to be delivered (whether physically, deemed to be delivered pursuant to Rule 153 or through compliance with Rule 172 of the Rules and Regulations or any similar rule) in
    connection with sales of the Shares (the &#8220;<b>Prospectus Delivery Period</b>&#8221;), the Registration Statement complied and will comply in all material respects with the Act and the Rules and Regulations, and did not and will not contain an untrue statement
    of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. As of each Time of Sale and each Settlement Date and at all times during the Prospectus Delivery Period, the
    Prospectus, as amended or supplemented, complied and will comply in all material respects with the Act and the Rules and Regulations, and, together with all of the then issued Permitted Free Writing Prospectuses, if any, did not and will not contain
    any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The Base Prospectus (including any amendment
    thereto) complied when so filed in all material respects with the Rules and Regulations, and the Prospectus (including the Base Prospectus included therein) delivered to the Agents for use in connection with the transactions contemplated by this
    Agreement is identical to the electronically transmitted copy thereof filed with the Commission on EDGAR, except to the extent permitted by Regulation S-T. The foregoing representations and warranties in this Section 2(b) do not apply to any statements
    contained in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus in reliance upon and in conformity with information relating to the Agents furnished in writing to the Company by such Agent specifically for inclusion in
    the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus (or any amendment or supplement thereto), which constitutes the information set forth in <b><u>Schedule 2</u></b> hereto. &#8220;<b>Time of Sale</b>&#8221; means, (i) with respect
    to an Agency Transaction, the time of the applicable Agent&#8217;s initial entry into contracts with investors for the sale of such Shares and (ii) with respect to a Principal Transaction, the time of sale of such Shares.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Documents Incorporated by Reference.</i> The Incorporated Documents, at the time they were or hereafter are filed with the Commission, conformed and
    will conform in all material respects to the requirements of the Act or the Exchange Act, as applicable, and, when read together with the other information in the Prospectus, at the time the Registration Statement and any amendments thereto become
    effective, as of each Time of Sale and each Settlement Date and at all times during the Prospectus Delivery Period, will not contain an untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in
    the light of the circumstances under which they were made, not misleading.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Company Not Ineligible Issuer</i>. (i) At the time of filing the Registration Statement, (ii) at the earliest time that the Company or another offering
    participant made a <i>bona fide</i> offer (within the meaning of Rule 164(h)(2) of the Rules and Regulations) of the Shares and (iii) at the date hereof, the Company was not and is not an &#8220;ineligible issuer&#8221; (as defined in Rule 405 of the Rules and
    Regulations).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Free Writing Prospectuses. </i>Any free writing prospectus that the Company is required to file pursuant to Rule 433(d) of the Rules and Regulations
    has been, or will be, filed with the Commission in accordance with the requirements of the Act and the Rules and Regulations. Each free writing prospectus that the Company has filed, or is required to file, pursuant to Rule 433(d) of the Rules and
    Regulations or that was prepared by or on behalf of or used or referred to by the Company complies or will comply in all material respects with the requirements of the Act and the Rules and Regulations. Each free writing prospectus, as of its issue
    date and at all subsequent times through the completion of the offer and sale of the Shares or until any earlier date that the Company notified or notifies the Agents, did not, does not and will not include any material information that conflicted,
    conflicts or will conflict with the information contained in the Registration Statement or the Prospectus. Except for the Permitted Free Writing Prospectuses, if any, the Company has not prepared, used or referred to, and will not, prepare, use or
    refer to, any free writing prospectus.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 5; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Due Incorporation; Subsidiaries</i>. The Company has been duly incorporated, is validly existing as a corporation and is in good standing under the laws
    of its jurisdiction of incorporation. The Company has full corporate power and authority to own or lease all the assets owned or leased by it and to conduct its business as described in the Registration Statement and the Prospectus. The Company is duly
    licensed or qualified to do business in and in good standing as a foreign corporation in all jurisdictions in which the nature of the activities conducted by it or the character of the assets owned or leased by it makes such licensing or qualification
    necessary, except to the extent that the failure to be so licensed or qualified or be in good standing would not reasonably be expected to have a material adverse effect on the business, properties, assets, business prospects, condition (financial or
    otherwise), results of operations or capitalization of the Company and its subsidiaries, taken as a whole (a &#8220;<b>Material Adverse Effect</b>&#8221;). Each subsidiary has been duly incorporated or formed, is validly existing as a corporation, limited
    liability company or limited partnership and is in good standing under the laws of its jurisdiction of incorporation or formation. Each subsidiary of the Company has full corporate, limited liability company or limited partnership power and authority
    to own or lease all the assets owned or leased by it and to conduct its business as described in the Registration Statement and the Prospectus. Each subsidiary of the company is duly licensed or qualified to do business in and in good standing as a
    foreign corporation, limited liability company or limited partnership in all jurisdictions in which the nature of the activities conducted by it or the character of the assets owned or leased by it makes such licensing or qualification necessary,
    except to the extent that the failure to be so licensed or qualified or be in good standing would not reasonably be expected to have a Material Adverse Effect.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Capitalization.</i> The authorized, issued and outstanding capital stock of the Company is as set forth in the Registration Statement and the
    Prospectus. The outstanding shares of Common Stock and any other outstanding capital stock of the Company have been, and the Shares will be when issued in accordance with this Agreement (in the case of an Agency Transaction) or a Terms Agreement (in
    the case of a Principal Transaction), duly authorized, validly issued, fully paid and non-assessable and will not be subject to any preemptive, first refusal, or similar right. The description of the Common Stock included or incorporated by reference
    in the Registration Statement and the Prospectus is complete and accurate in all material respects. Except as described in the Registration Statement and the Prospectus, the Company does not have outstanding any options to purchase, or any rights or
    warrants to subscribe for, or any securities or obligations convertible into, or any contracts or commitments to issue or sell, any shares of capital stock of the Company or of any subsidiary of the Company or any such warrants, convertible securities
    or obligations. All of the outstanding shares of capital stock or other equity interests of each subsidiary owned, directly or indirectly, by the Company have been duly authorized and validly issued, are fully paid and non-assessable (except, in the
    case of any foreign subsidiary, for directors&#8217; qualifying shares), are not be subject to any preemptive, first refusal, or similar right, and are owned directly or indirectly by the Company, free and clear of any lien, charge, encumbrance, security
    interest, restriction on voting or transfer or any other claim of any third party, except as described in the Registration Statement and the Prospectus, arising out of the Gold Sale and Purchase Agreement between Franco-Nevada (Barbados) Corporation,
    Coeur Mexicana, S.A. de C.V., Ocampo Resources, Inc. and Ocampo Services, Inc. dated as of October 2, 2014, or as are not material to the business of the Company or its subsidiaries.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Financial Statements.</i> (i) The consolidated financial statements of the Company and its subsidiaries (including the related notes thereto) and
    schedules included or incorporated by reference in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus comply in all material respects with the applicable requirements of the Act and the Exchange Act, as applicable, and
    present fairly the financial condition of the Company and its consolidated subsidiaries as of the date(s) indicated and the results of their respective operations and the changes in their respective cash flows for the periods specified; such financial
    statements have been prepared in conformity with U.S. generally accepted accounting principles (&#8220;<b>GAAP</b>&#8221;) applied on a consistent basis throughout the periods covered thereby, except as otherwise disclosed in the financial statement footnotes, and
    the supporting schedules included or incorporated by reference in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus present fairly the information required to be stated therein; and the other financial information
    included or incorporated by reference in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus has been derived from the accounting records of the Company and its subsidiaries and presents fairly the information shown
    thereby.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <!-- Field: Page; Sequence: 6; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Independent Accountant.</i> The accountants who have reported on the financial statements and schedules included or incorporated by reference in the
    Registration Statement, the Prospectus and any Permitted Free Writing Prospectus (the &#8220;<b>Accountants</b>&#8221;), are (i) independent accountants with respect to the Company as required by the Act and the Rules and Regulations and by Rule&#160;3600T of the
    Public Company Accounting Oversight Board (&#8220;<b>PCAOB</b>&#8221;), (ii) in compliance with the applicable requirements relating to the qualification of accountants under Rule 2-01 of Regulation S-X under the Act, and (iii) a registered public accounting firm
    as defined by the PCAOB whose registration has not been suspended or revoked and who has not requested such registration to be withdrawn. Except as described in the Prospectus and as preapproved in accordance with the requirements set forth in Section
    10A of the Exchange Act, the Accountants have not engaged in any &#8220;prohibited activities&#8221; (as defined in Section&#160;10A of the Exchange Act) on behalf of the Company. The statements included in the Registration Statement with respect to the Accountants
    pursuant to Rule 509 of Regulation S-K of the Rules and Regulations are true and correct in all material respects.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;[Intentionally Omitted]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>No Material Adverse Changes.</i> Since the date of the most recent financial statements of the Company included or incorporated by reference in the
    Registration Statement and the Prospectus, there has not been and will not have been a material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its subsidiaries
    considered as one enterprise, whether or not arising in the ordinary course of business (a &#8220;<b>Material Adverse Change</b>&#8221;).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Investment Company.</i> The Company is not, and after giving effect to the offering and sale of the Shares and the use of the proceeds therefrom as
    described in the Registration Statement and the Prospectus will not be an &#8220;investment company&#8221; or an &#8220;affiliated person&#8221; of, or &#8220;promoter&#8221; or &#8220;principal underwriter&#8221; for, an &#8220;investment company,&#8221; as such terms are defined in the Investment Company Act
    of 1940, as amended.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Litigation.</i> Except as set forth in the Registration Statement and the Prospectus, there are no actions, suits or proceedings pending, or to the
    Company&#8217;s knowledge, threatened against or affecting, the Company or any of its subsidiaries or any of their respective officers in their capacity as such, before or by any federal or state court, commission, regulatory body (including, without
    limitation, the Financial Industry Regulatory Authority, Inc. (&#8220;<b>FINRA</b>&#8221;) and the Exchange), administrative agency or other governmental body, in each case whether domestic or foreign, wherein an unfavorable ruling, decision or finding would
    reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or modification of any authorization, approval, order, license, certificate,
    franchise or permit, which revocation or modification would reasonably be expected to have a Material Adverse Effect. There are no pending investigations known to the Company involving the Company or any of its subsidiaries by any governmental agency
    having jurisdiction over the Company or any of its subsidiaries or their respective businesses or operations, which investigations would reasonably be expected to have a Material Adverse Effect.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Necessary Licenses, Compliance with Laws and Regulations and Performance of Obligations and Contracts.</i> Each of the Company and its subsidiaries has
    (i) all governmental and other regulatory licenses, permits, consents, orders, approvals and other authorizations necessary to carry on its business as described in the Prospectus; (ii) complied in all respects with all laws, regulations and orders
    applicable to it and its business and (iii) performed all obligations required to be performed by it, and is not in default under any indenture, mortgage, deed of trust, voting trust agreement, loan agreement, bond, debenture, note agreement, lease or
    other agreement or instrument (individually, a &#8220;<b>Contract</b>&#8221; and collectively, &#8220;<b>Contracts</b>&#8221;) to which it is a party or by which its property is bound or affected, except, in each case, where the failure to do so or where such default would
    not reasonably be expected to have a Material Adverse Effect. Each Contract was duly authorized, executed and delivered by the Company or the relevant subsidiary of the Company, constitutes valid and binding agreements of the Company or such subsidiary
    of the Company and are enforceable against the Company or such subsidiary of the Company in accordance with the terms thereof, except, in each case, where the failure to do so or where such default would not reasonably be expected to have a Material
    Adverse Effect. To the knowledge of the Company, no other party under any material Contract to which it or its subsidiaries is a party is in default in any respect thereunder or has given written, or, to the knowledge of the officers and directors of
    the Company, oral, notice to the Company, its subsidiaries or any of their respective officers or directors of such other party&#8217;s intention to terminate, cancel or refuse to renew any material Contract. Each of the Company and its subsidiaries is not
    in violation of any provision of its certificate of incorporation or by-laws.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 7; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>No Consent of Governmental Body Needed.</i> No consent, approval, authorization, license, registration, qualification, or order of, or any filing or
    declaration with, any court or arbitrator or governmental or regulatory authority, agency or body is required in connection with the authorization, issuance, transfer, sale or delivery of the Shares by the Company, in connection with the execution,
    delivery and performance of this Agreement by the Company or in connection with a Terms Agreement or the taking by the Company of any action contemplated hereby or thereby, except as have been obtained under the Act and such as may be required under
    state securities or Blue Sky laws or the by-laws and rules of FINRA in connection with the purchase and distribution by the Agents of the Shares to be sold by the Company hereby or thereby.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Agreement Duly Authorized and No Breach of Obligations or Charter.</i> The Company has full corporate power and authority to enter into this Agreement
    and each Terms Agreement. This Agreement has been, and any Terms Agreement will have been, duly authorized, executed and delivered by the Company and this Agreement constitutes, and any Terms Agreement will constitute, a valid and binding agreement of
    the Company enforceable against the Company in accordance with the terms hereof or thereof, as the case may be, except as the enforcement may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws relating to
    or affecting creditors&#8217; rights generally or general equitable principles.&#160; The execution and delivery by the Company of this Agreement and any Terms Agreement and the performance of this Agreement and any Terms Agreement, the consummation of the
    transactions contemplated hereby and thereby, and the application of the net proceeds from the offering and sale of the Shares to be sold by the Company in the manner set forth in the Prospectus under &#8220;Use of Proceeds&#8221; do not and will not (i) violate
    the certificate of incorporation or by-laws of the Company or any subsidiary of the Company or (ii) result in the creation or imposition of any lien, charge or encumbrance upon any of the assets of the Company or any subsidiary of the Company pursuant
    to the terms or provisions of, or result in a breach or violation of any of the terms or provisions of, or constitute a default under, or give any other party a right to terminate any of its obligations under, or result in the acceleration of any
    obligation under any Contract to which the Company or any of its subsidiaries is a party or by which the Company or any of its subsidiaries or any of its properties is bound or affected, or violate or conflict with any judgment, ruling, decree, order,
    statute, rule or regulation of any court or other governmental agency or body applicable to the business or properties of the Company or any of its subsidiaries (except for such violations, breaches or defaults or liens, charges or encumbrances that
    would not reasonably be expected to have a Material Adverse Effect). This Agreement conforms in all material respects to the description thereof contained in the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Documents Described in Registration Statement.</i> There is no document or Contract of a character required to be described or incorporated by reference
    in the Registration Statement or the Prospectus or to be filed as an exhibit to the Registration Statement that is not described or filed as required.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Statistical and Market Data.</i> All statistical or market-related data included in the Registration Statement or the Prospectus are based on or derived
    from sources that the Company believes to be reliable and accurate, and the Company has obtained the written consent to the use of such data from such sources to the extent required.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>No Price Stabilization or Manipulation.</i> Neither the Company nor any of its directors, officers or controlling persons has taken, directly or
    indirectly, any action intended to cause or result in, or which might reasonably be expected to cause or result in, or which has constituted, stabilization or manipulation, under the Act or otherwise, of the price of any security of the Company to
    facilitate the sale or resale of the Shares.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 8; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>No Registration Rights.</i> No holder of securities of the Company has rights to register any securities of the Company as a result of the filing of the
    Registration Statement or Prospectus or consummation of the transactions contemplated hereby, except for rights that have been duly waived by such holder, have expired or have been fulfilled by registration prior to the date of this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Stock Exchange Listing.</i> Prior to the first Settlement Date hereunder, the Shares will be duly authorized for listing on the Exchange, subject only
    to notice of issuance. The Company is not the subject of a de-listing or any other order preventing or suspending trading of any securities of the Company issued by the Exchange, and the Company is, to its knowledge, not aware of any such order being
    contemplated or threatened by the Exchange.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Labor Matters.</i> Except as set forth in the Registration Statement or Prospectus, neither the Company nor any of its subsidiaries:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;is a party to any collective bargaining agreement; or is subject to any application for certification or, to the knowledge of the Company, threatened or
    apparent union-organizing campaigns for employees not covered under a collective bargaining agreement, except where such application or union-organizing campaigns would not, individually or in the aggregate, have a Material Adverse Effect;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;is involved in any labor strike, lock-out, slowdown or work stoppage, except where the dispute would not, individually or in the aggregate, have a
    Material Adverse Effect, and, to the knowledge of the Company, no such dispute is threatened;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;is subject to any claim for wrongful dismissal, constructive dismissal or any other tort claim, actual or, to the knowledge of the Company, threatened, or
    any litigation actual, or to the knowledge of the Company, threatened, relating to employment or termination of employment of employees or independent contractors, except for such claims or litigation which individually or in the aggregate would not be
    reasonably expected to have a Material Adverse Effect;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;has entered into any written or oral agreement or understanding providing for severance or termination payments to any named executive officer (as such
    term is used in Regulation S-K, Item 402(a)(3)) in connection with the termination of their position or their employment as a direct result of a change in control of the Company; and</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;is in violation or has violated any applicable laws with respect to employment and labor, including, but not limited to, employment and labor standards,
    occupational health and safety, employment equity, pay equity, workers&#8217; compensation, human rights, labor relations and privacy, and there are no current, pending, or to the knowledge of the Company, threatened proceedings before any court, agency,
    board or tribunal with respect to any of the areas listed in this subsection 2(u)(v), except where the violation or proceeding would not reasonably be expected to have a Material Adverse Effect.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Taxes.</i> Except as set forth in the Registration Statement or Prospectus, and except as would not, individually or in the aggregate, reasonably be
    expected to have a Material Adverse Effect:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;each of the Company and its subsidiaries has duly and timely filed all federal, state and foreign income and other tax returns required to be made or
    prepared by it (each, a &#8220;<b>Tax Return</b>&#8221; and collectively, the &#8220;<b>Tax Returns</b>&#8221;), with the appropriate governmental entity or authority and has, in all material respects, completely and correctly reported all income and all other amounts or
    information required to be reported thereon;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;has (A) duly and timely paid all Taxes due and payable by it, (B) duly and timely withheld all Taxes and other amounts required by applicable laws to be
    withheld by it and has duly and timely remitted to the appropriate governmental entity or authority such Taxes and other amounts required by applicable laws to be remitted by it, and (C) duly and timely collected all amounts on account of sales or
    transfer taxes, including goods and services, harmonized sales and provincial or territorial sales taxes, required by applicable laws to be collected by it and has duly and timely remitted to the appropriate governmental entity or authority any such
    amounts required by applicable laws to be remitted by it;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <!-- Field: Page; Sequence: 9; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the charges, accruals and reserves for Taxes reflected on the financial statements referred to in subsection (h) of this Section 2 (whether or not due and
    whether or not shown on any Tax Return, but excluding any provision for deferred income taxes) are, in the opinion of the Company, adequate under GAAP, as applicable, to cover Taxes with respect to the Company and the subsidiaries accruing through the
    date hereof;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;there are no proceedings, investigations, audits, assessments, reassessments or claims now pending or, to the knowledge of the Company, threatened against
    any of the Company or the subsidiaries that propose to assess Taxes in addition to those reported in the Tax Returns; and</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;no waiver of any statutory limitation period with respect to Taxes has been given to, or requested by, a taxing authority with respect to the Company or
    any of the subsidiaries.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">For the purposes of this Agreement, <b>&#8220;Tax&#8221;</b> and <b>&#8220;Taxes&#8221;</b> means all taxes, assessments, charges, dues, duties, rates, fees, imposts, levies and similar
    charges of any kind lawfully levied, assessed or imposed by any governmental entity or authority, including all income taxes (including any tax on or based upon net income, gross income, income as specially defined, earnings, profits or selected items
    of income, earnings or profits) and all capital taxes, gross receipts taxes, environmental taxes, sales taxes, use taxes, <i>ad valorem</i> taxes, value added taxes, transfer taxes (including, without limitation, taxes relating to the transfer of
    interests in real property or entities holding interests therein), franchise taxes, license taxes, withholding taxes, payroll taxes, employment taxes, pension plan premiums, excise, severance, social security, workers' compensation, employment
    insurance or compensation taxes or premium, stamp taxes, occupation taxes, premium taxes, property taxes, harmonized sales taxes, windfall profits taxes, alternative or add-on minimum taxes, goods and services tax, customs duties or other taxes, fees,
    imports, assessments or charges of any kind whatsoever, together with any interest and any penalties or additional amounts imposed by any taxing authority (domestic (whether provincial, federal, state or local) or foreign) on such entity, and any
    interest, penalties, additional taxes and additions to tax imposed with respect to the foregoing.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(w)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Insurance.</i> Each of the Company and its subsidiaries carries, or is covered by, insurance in such amounts and covering such risks as it believes is
    adequate for the conduct of its business and the value of its properties and is customary for companies engaged in similar industries, and all such insurance is in full force and effect. The Company has no reason to believe that it and its subsidiaries
    will not be able to (i) renew their existing insurance coverage as and when such policies expire or (ii) obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct their business as currently conducted or
    proposed to be conducted and at a cost that would not, individually or in the aggregate, result in a Material Adverse Effect. Neither the Company nor any of its subsidiaries has been denied any insurance coverage which it has sought or for which it has
    applied where such denial would or has resulted in a Material Adverse Effect.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Employee Benefit Plans.</i> Neither the Company nor any of its subsidiaries maintains or contributes to, or has any liability with respect to, a defined
    benefit plan as defined in Section&#160;3(35) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;<b>ERISA</b>&#8221;). No plan maintained or contributed to by the Company that is subject to ERISA (an &#8220;<b>ERISA Plan</b>&#8221;) (or any trust created
    thereunder) has engaged in a &#8220;prohibited transaction&#8221; within the meaning of Section&#160;406 of ERISA or Section&#160;4975 of the Internal Revenue Code of 1986, as amended (the &#8220;<b>Code</b>&#8221;) that could subject the Company or any of its subsidiaries to any
    material tax penalty on prohibited transactions and that has not adequately been corrected. Each ERISA Plan is in compliance with all operational, reporting, disclosure and other requirements of the Code and ERISA as they relate to such ERISA Plan,
    except for any noncompliance that would not result in the imposition of a material tax or monetary penalty. With respect to each ERISA Plan that is intended to be &#8220;qualified&#8221; within the meaning of Section 401(a) of the Code, either (i) a determination
    or opinion letter has been issued by the Internal Revenue Service stating that such ERISA Plan and the attendant trust are qualified thereunder or (ii) the remedial amendment period under Section 401(b) of the Code with respect to the establishment of
    such ERISA Plan has not ended and a determination letter application will be filed with respect to such ERISA Plan prior to the end of such remedial amendment period. Neither the Company nor any of its subsidiaries has any unsatisfied liability with
    respect to a &#8220;multiemployer plan,&#8221; as defined in Section&#160;3(37) of ERISA.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 10; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Title to Intellectual Property.</i> Except as described in the Registration Statement and the Prospectus, each of the Company and its subsidiaries owns,
    is licensed or otherwise has adequate rights to use Company technology (including, without limitation, patented, patentable and unpatented inventions and unpatentable proprietary or confidential information, systems or procedures), designs, processes,
    trademarks, trade secrets, know how, copyrights and other works of authorship, computer programs and technical data and information that are or could reasonably be expected to be material to its business as currently conducted or as currently proposed
    to be conducted.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Title to Real and Personal Property.</i> The Company and each of its subsidiaries has good and marketable title to all properties and assets described
    or incorporated by reference in the Prospectus as being owned respectively by it, free and clear of all liens, charges, encumbrances or restrictions (other than liens, charges, encumbrances or restrictions arising out of the Gold Sale and Purchase
    Agreement between Franco-Nevada (Barbados) Corporation, Coeur Mexicana, S.A. de C.V., Ocampo Resources, Inc. and Ocampo Services, Inc. dated as of October 2, 2014), except as described in the Registration Statement and the Prospectus or as are not
    material to the business of the Company or its subsidiaries. Each of the Company and its subsidiaries has valid, subsisting and enforceable leases for the properties described or incorporated by reference in the Prospectus as leased by it, with such
    exceptions as are not material and do not materially interfere with the use made and proposed to be made of such properties by the Company and its subsidiaries.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(aa)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Mining Rights</i>.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except as set forth in the Registration Statement, the Palmarejo mine and complex, the Rochester mine, the Kensington mine, the Wharf mine, and the
    Silvertip mine, each as described in the Registration Statement and the Prospectus (each a &#8220;<b>Material Property</b>&#8221; and collectively, the &#8220;<b>Material Properties</b>&#8221;), are the only resource properties that are currently material to the Company in
    which the Company or the subsidiaries have an interest.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company directly or through its subsidiaries, holds an interest in fee or freehold title, mining leases, mining concessions, mining claims, exploration
    permits, prospecting permits, participant interests, conventional property agreements, or proprietary interests or rights, recognized in the jurisdiction in which the Material Properties are located, in respect of the ore bodies and minerals located on
    the Material Properties in which the Company (through the applicable subsidiary) has an interest under valid, subsisting and enforceable title documents or other recognized and enforceable agreements, contracts, arrangements or understandings,
    sufficient to permit the Company (through the applicable subsidiary) to explore for and exploit the minerals relating thereto, and all such agreements, contracts, arrangements or understandings in connection with the Material Properties are valid and
    subsisting and enforceable in accordance with their terms.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;All material concessions, leases, property agreements and contracts, claims and permits relating to the Material Properties in which the Company (through
    the applicable subsidiary) has an interest or right have been validly granted, located, approved, executed and recorded or filed in accordance with all applicable laws and are valid, subsisting and enforceable.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except as disclosed in the Registration Statement or the Prospectus, the Company (through the applicable subsidiary) has all necessary surface rights,
    access rights and other necessary rights and interests relating to the Material Property in which the Company (through the applicable subsidiary) has an interest granting the Company (through the applicable subsidiary) the right and ability to explore
    for and exploit minerals, ore and metals for development and production purposes as are appropriate in view of the rights and interest therein of the Company or the applicable subsidiary, with only such exceptions as do not materially interfere with
    the current use made by the Company or the applicable subsidiary of the rights or interest so held, and each of the proprietary interests or rights and each of the agreements, contracts, arrangements or understandings and obligations relating thereto
    referred to above is currently in good standing in all material respects in the name of the Company or the applicable subsidiary.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Except as disclosed in the Prospectus, the Company and the subsidiaries do not have any responsibility or obligation to pay any commission, royalty,
    license, fee, assessment or similar payment to any person with respect to the property rights thereof, except where such fee or payment would not reasonably be expected to have a Material Adverse Effect, either individually or in the aggregate.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <!-- Field: Page; Sequence: 11; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company and the subsidiaries have identified all the material permits, certificates, and approvals (collectively, the &#8220;<b>Permits</b>&#8221;) which are or
    will be required for the exploration, development and eventual or actual operation of the Material Properties, which Permits include but are not limited to mine and reclamation permits, access and use grants and permits, environmental assessment
    certificates, water appropriation and use permits, licenses and applications, land tenures, rezoning or zoning variances and other necessary local, provincial, state and federal approvals; and, except as disclosed in the Registration Statement or the
    Prospectus, the appropriate Permits have either been received, applied for, or the processes to obtain such Permits have been or will in due course be initiated by the Company or the applicable subsidiaries; and, except as disclosed in the Registration
    Statement or the Prospectus, neither the Company nor the applicable subsidiaries know of any issue or reason why the Permits should not be approved and obtained in the ordinary course.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(vii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;All assessments or other work required to be performed in relation to the material mining claims and mining rights of the Company and the applicable
    subsidiary in order to maintain their respective interests therein, if any, have been performed to date and, except as disclosed in the Registration Statement or the Prospectus, the Company and the applicable subsidiary have complied in all respects
    with all applicable laws in this regard as well as with regard to legal and contractual obligations to third parties in this regard except in respect of mining claims and mining rights that the Company and the applicable subsidiary intend to abandon or
    relinquish and except for any non-compliance which would not either individually or in the aggregate have a Material Adverse Effect.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(bb)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Mining Practice</i>. Except as disclosed in the Registration Statement and the Prospectus, all mining operations by the Company and its subsidiaries on
    the Material Properties have for the past five years been conducted with the exercise of reasonable diligence, skill, care and prudence for mining operations in similar locations under similar circumstances.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(cc)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Technical Reports. </i> <b><u>Schedule 2(cc)</u></b> sets out each applicable current technical report relating to the Material Properties (the &#8220;<b>Reports</b>&#8221;).


    Each Report was at the time of filing compliant, in all material respects, with the requirements of the provisions of subpart 1300 of Regulation S-K under the Securities Exchange Act of 1934, as amended (&#8220;<b>SK-1300</b>&#8221;). All scientific and technical
    information disclosed in the Registration Statement and Prospectus: (i) is based upon information prepared by or under the supervision of, or approved by, a &#8220;qualified person&#8221; (as such term is defined in SK-1300) and (ii) was true, complete and
    accurate in all material respects at the time of filing. The Company made available to the respective authors thereof prior to the issuance of all of the Reports, for the purpose of preparing the Reports, as applicable, all information requested, and
    no such information contained any misrepresentation as at the time the relevant information was made available. The Reports, as of their respective dates, accurately and completely set forth all material facts relating to the Material Properties, and
    as of the date hereof and the date of the Prospectus, there is no new material scientific or technical information concerning any of the Material Properties not included in the Reports.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Environmental Matters</i>. Except as described in the Registration Statement and the Prospectus, and except as would not reasonably be expected,
    individually or in the aggregate, to have a Material Adverse Effect:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;each of the Company and its subsidiaries is in compliance in all material respects with all applicable federal, provincial, state, municipal and local
    laws, statutes, ordinances, regulations and orders, directives and decisions rendered by any ministry, department or administrative or regulatory agency, whether domestic or foreign, in each case, relating to the protection of the environment, the
    processing, use, treatment, storage, disposal, discharge, transport or handling of any pollutants, contaminants, chemicals, substances or industrial wastes classified as toxic or hazardous to human health or the environment (the &#8220;<b>Hazardous
      Substances</b>&#8221;), or with respect to Hazardous Substances, occupational health and safety (collectively, the &#8220;<b>Environmental Laws</b>&#8221;);</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <!-- Field: Page; Sequence: 12; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the Company and its subsidiaries have all permits, licenses, authorizations and approvals required under any applicable Environmental Law (&#8220;<b>Environmental


      Permits</b>&#8221;) and are in compliance with all terms and conditions of each Environmental Permit;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;there are no pending or, to the Company&#8217;s knowledge, threatened administrative, regulatory or judicial actions, suits, demands, claims, liens,
    investigation or proceedings against the Company or any of its subsidiaries, relating to any alleged violation of or liability under Environmental Law;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;neither the Company nor any of subsidiary has failed to report to the proper governmental authority the occurrence of any event which is required to be so
    reported by any Environmental Laws;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;neither the Company nor any of its subsidiaries is subject to (A) any Environmental Laws that require or may require any material work, repairs,
    construction, change in business practices or operations, or any expenditures, including capital expenditures, for facility upgrades to mitigate, control, or limit releases of Hazardous Substances into the environment, environmental investigation and
    remediation, or corrective actions, except with respect to any remediation obligations required as part of mine reclamation and covered under existing reclamation surety bonds or pursuant to or in accordance with Environment Permits; (B) any written
    demand, written notice of default, summons, notice of judgment or commencement of proceedings with respect to any alleged violation of or liability arising under Environmental Laws; or (C) any outstanding obligations to remedy, pay compensation, or
    make any payment in the nature of a fine in relation to any violation of Environmental Laws; and</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;there are no events or circumstances that would reasonably be expected to form the basis of an order for clean-up or remediation, or an action, suit or
    proceeding by any private party or governmental body or agency, against or affecting the Company or any of its subsidiaries pursuant to any Environmental Laws.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(ee)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Trademarks. </i>Each of the Company and its subsidiaries owns, or is licensed or otherwise has the full right to use, all material trademarks and trade
    names that are used in or reasonably necessary for the conduct of their respective businesses as described in the Prospectus.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(ff)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Protection of Intellectual Property.</i> Each of the Company and its subsidiaries has taken reasonable security measures to protect the secrecy,
    confidentiality and value of all their Intellectual Property in all material respects.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(gg)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Related Party Transactions.</i> There are no business relationships or related party transactions involving the Company or any other person required to
    be described in the Prospectus that have not been described or incorporated therein by reference. Without limiting the generality of the immediately preceding sentence, no relationship, direct or indirect, exists between or among the Company or any
    subsidiary of the Company on the one hand, and the directors, officers, stockholders, customers or suppliers of the Company on the other hand, that is required to be described in the Prospectus and that is not so described or incorporated therein by
    reference. Within the last three years, the Company has not, directly or indirectly, extended or maintained credit, arranged to extend credit, or renewed any extension of credit, in the form of a personal loan, to or for any director or executive
    officer of the Company, or to or for any family member or affiliate of any director or executive officer of the Company in violation of applicable laws, including Section 13(k) of the Exchange Act.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(hh)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>No Prohibition on its Subsidiaries from Paying Dividends or Making Other Distributions.</i> No subsidiary of the Company is currently prohibited,
    directly or indirectly, from paying any dividends to the Company, from making any other distribution on its capital stock, from repaying to the Company any loans or advances from the Company or from transferring any of its property or assets to the
    Company or any other subsidiary of the Company of the Company, except as described in the Registration Statement and the Prospectus.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 13; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Controls and Procedures.</i></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Disclosure Controls and Procedures. </i>The Company has established and maintains disclosure controls and procedures (as such term is defined in
    Rule&#160;13a-15 and 15d-15 under the Exchange Act), that (A) are designed to ensure that material information required to be disclosed by the Company in the reports it files and submits under the Exchange Act is accumulated and communicated to the
    management of the Company, including its principal executive officer and its principal financial officer, as appropriate, to allow timely decisions regarding required disclosure to be made; (B) provide for the periodic evaluation of the effectiveness
    of such disclosure controls and procedures as of the end of the period covered by the Company&#8217;s most recent annual or quarterly report filed with the Commission; and (C) are effective in all material respects to perform the functions for which they
    were established.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Internal Control Over Financial Reporting and Internal Accounting Controls</i>. Except as disclosed in the Registration Statement, the Company maintains
    (i) &#8220;effective internal control over financial reporting&#8221; as defined in, and in compliance with, Rules 13a-15 and 15d-15 under the Exchange Act, and (ii) a system of internal accounting controls sufficient to provide reasonable assurance that
    (A)&#160;transactions are executed in accordance with management&#8217;s general or specific authorizations; (B)&#160;transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain asset accountability;
    (C)&#160;access to assets is permitted only in accordance with management&#8217;s general or specific authorization; and (D)&#160;the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with
    respect to any differences; and (E) the interactive data in eXtensible Business Reporting Language incorporated by reference in the Registration Statement, the General Disclosure Package and the Prospectus fairly presents the required information and
    is prepared in accordance with the Commission's rules and guidelines applicable thereto.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>No Material Weakness in Internal Controls. </i>Except as disclosed in the Registration Statement, the Company is not aware of (i) any material weakness
    in the Company&#8217;s internal control over financial reporting (whether or not remediated); (ii) any change in the Company&#8217;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s
    internal control over financial reporting; or (iii) any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#8217;s internal controls.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(jj)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Off-Balance Sheet Transactions.</i> Except as described in the Registration Statement and the Prospectus, there are no material off-balance sheet
    transactions (including, without limitation, transactions related to, and the existence of, &#8220;variable interest entities&#8221; within the meaning of Financial Accounting Standards Board Accounting Standards Codification Topic 810), arrangements, obligations
    (including, without limitation, contingent obligations), or any other relationships with unconsolidated entities or other persons, that may have a material current or future effect on the Company&#8217;s financial condition, changes in financial condition,
    results of operations, liquidity, capital expenditures, capital resources, or significant components of revenues or expenses.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(kk)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Audit Committee.</i> The Company&#8217;s board of directors (the &#8220;<b>Board of Directors</b>&#8221;) has validly appointed an audit committee whose composition
    satisfies the requirements of Section 10A of, and Rule&#160;10A-3 under, the Exchange Act, and the Board of Directors and/or the audit committee has adopted a charter that satisfies the requirements of Section 10A of, and Rule&#160;10A-3 under, the Exchange Act.
    As of the date of this Agreement, neither the Board of Directors nor the audit committee has been informed, nor is any director of the Company aware, of (i) any significant deficiency in the design or operation of the Company&#8217;s internal control over
    financial reporting which is reasonably likely to adversely affect the Company&#8217;s ability to record, process, summarize and report financial data or any material weakness in the Company&#8217;s internal controls; or (ii) any fraud, whether or not material,
    that involves management or other employees of the Company who have a significant role in the Company&#8217;s internal controls.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(ll)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Sarbanes-Oxley.</i> The Company is, and after giving effect to the offering and sale of the Shares will be, in compliance in all material respects with
    all applicable effective provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations of the Commission promulgated thereunder.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(mm)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;[Intentionally Omitted]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 14; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(nn)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>No Unlawful Contributions or Payments.</i> Neither the Company nor any of its subsidiaries, nor any director, or executive officer of the Company, nor,
    to the knowledge of the Company, any other officer, agent, employee or representative of the Company or its subsidiaries or other person associated with or acting on behalf of the Company or its subsidiaries, has (i) used any corporate funds for any
    unlawful contribution, gift, entertainment or other unlawful expense relating to political activity; (ii) made or taken an act in furtherance of an offer, promise or authorization of any direct or indirect unlawful payment of corporate funds or benefit
    to any foreign or domestic government or regulatory official or employee, including, without limitation, of any government-owned or controlled entity or of a public international organization, or any person acting in an official capacity for or on
    behalf of any of the foregoing, or any political party or party official or candidate for political office; (iii) violated or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, the U.K. Bribery Act 2010, or
    any applicable law or regulation implementing the OECD Convention on Combating Bribery of Foreign Public Officials in International Business Transactions, or committed an offense under any other applicable anti-bribery or anti-corruption laws; or (iv)
    made, offered, agreed, requested or taken an act in furtherance of any unlawful bribe or other unlawful benefit, including, without limitation, any rebate, payoff, influence payment, kickback or other unlawful or improper payment or benefit. The
    Company has instituted, maintained and enforced, and will continue to maintain and enforce policies and procedures designed to promote and ensure compliance with all applicable anti-bribery and anti-corruption laws.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(oo)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Compliance with Anti-Money Laundering Laws.</i> The operations of the Company and its subsidiaries are and have been conducted at all times in
    compliance with applicable financial recordkeeping and reporting requirements, including those of the Currency and Foreign Transactions Reporting Act of 1970, as amended, those of the Bank Secrecy Act, as amended by Title III of the Uniting and
    Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism Act of 2001 (USA PATRIOT Act), and the applicable money laundering statutes of all jurisdictions in which the Company and its subsidiaries conduct
    business, the rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced by any governmental or regulatory agency (collectively, the &#8220;<b>Money Laundering Laws</b>&#8221;), and no action,
    suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company or its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(pp)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>No Conflicts with Sanctions Laws</i>. Neither the Company nor any of its subsidiaries, nor any director or executive officer of the Company, nor, to the
    knowledge of the Company, any director, officer, agent, employee or representative of the Company or its subsidiaries, affiliates or other person associated with or acting on behalf of the Company or its subsidiaries is currently the subject or target
    of any sanctions administered or enforced by the U.S. government (including, without limitation, the Office of Foreign Assets Control of the U.S. Treasury Department (&#8220;<b>OFAC</b>&#8221;) or the U.S. Department of State and including, without limitation, the
    designation as a &#8220;specially designated national&#8221; or &#8220;blocked person&#8221;), the United Nations Security Council, the European Union, Her Majesty&#8217;s Treasury or other relevant sanctions authority (collectively, &#8220;<b>Sanctions</b>&#8221;), nor is the Company or any
    of its subsidiaries located, organized or resident in a country or territory that is the subject or the target of Sanctions, including, without limitation, Cuba, Iran, North Korea, Sudan, Syria and Crimea (each, a &#8220;<b>Sanctioned Country</b>&#8221;); and the
    Company will not directly or indirectly use the proceeds of the offering of the Shares hereunder, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity (i) to fund or facilitate
    any activities of or business with any person that, at the time of such funding or facilitation, is the subject or the target of Sanctions, (ii) to fund or facilitate any activities of or business in any Sanctioned Country or (iii) in any other manner
    that will result in a violation by any person (including any person participating in the transaction, whether as agent, principal, advisor, investor or otherwise) of Sanctions. For the past five years, the Company and its subsidiaries have not
    knowingly engaged in, are not now knowingly engaged in, and will not engage in, any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(qq)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Brokers and Finders</i>. Neither the Company nor any of its subsidiaries is party to any contract, agreement or understanding with any person (other
    than this Agreement) that would reasonably be expected to give rise to a valid claim against the Company, any subsidiary of the Company or the Agents for a brokerage commission, finder&#8217;s fee or like payment in connection with the offering and sale of
    the Shares.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 15; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(rr)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Forward-Looking Statements</i>. No forward-looking statement (within the meaning of Section 27A of the Act and Section 21E of the Exchange Act) included
    or incorporated by reference in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(ss)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>XBRL</i>. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement and the
    Prospectus fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any certificate signed by any officer of the Company and delivered to the Agents or to counsel for the Agents shall be deemed a representation and warranty by the
    Company, as the case may be, to the Agents as to the matters covered thereby.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">3.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Agreements of the Company</u>. The Company covenants and agrees with each Agent as follows:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Amendments and Supplements to the Registration Statement, the Prospectus and any Permitted Free Writing Prospectus</i>. Other than with respect to any
    reports or documents and any preliminary or definitive proxy or information statement required to be filed by the Company with the Commission in order to comply with the Exchange Act, the Company shall not, during the Prospectus Delivery Period, amend
    or supplement the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, unless a copy of such amendment or supplement thereto (or such document) shall first have been submitted to the Agents within a reasonable period of time
    prior to the filing or, if no filing is required, the use thereof and the Agents shall not have objected thereto.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Material Misstatements or Omissions and Other Compliance with Applicable Law. </i>If, after the date hereof and during the Prospectus Delivery Period,
    any event or development shall occur or condition shall exist as a result of which the Prospectus or any Permitted Free Writing Prospectus as then amended or supplemented would include any untrue statement of a material fact or omit to state any
    material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if it shall be necessary to amend or supplement the Prospectus or any Permitted Free Writing Prospectus,
    or to file any document in order to comply with the Act or the Exchange Act, in order to make the statements therein, in the light of the circumstances under which they were made, not misleading, or if in the reasonable opinion of the Agents it is
    otherwise necessary to amend or supplement the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus or to file any document in order to comply with the Act or the Exchange Act, including, without limitation, in connection
    with the delivery of the Prospectus, the Company shall promptly (i) notify the Agents of any such event, development or condition (and confirm such notice in writing) and (ii)(x) prepare (subject to subsections (a) and (g) of this Section 3) an
    amendment or supplement to the Prospectus or such Permitted Free Writing Prospectus, necessary in order to make the statements in the Prospectus or such Permitted Free Writing Prospectus as so amended or supplemented, in the light of the circumstances
    under which they were made, not misleading or so that the Registration Statement, the Prospectus or such Permitted Free Writing Prospectus, as amended or supplemented, will comply with the Act or the Exchange Act, (y) file with the Commission such
    amendment, supplement or document in order to comply with the Act or the Exchange Act (and use its best efforts to have such amendment or supplement to be declared effective as soon as possible) and (z) furnish at its own expense to the Agents as many
    copies as the Agents may reasonably request of such amendment, supplement or document. The Company will comply with the Act, the Rules and Regulations, the Exchange Act and the rules and regulations promulgated under the Exchange Act so as to permit
    the completion of sales of Shares as contemplated in this Agreement and in the Registration Statement and the Prospectus.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Notifications to the Agents.</i> The Company shall notify the Agents promptly, and shall confirm such notice in writing, (i) when any post-effective
    amendment to the Registration Statement becomes effective, (ii) of any request by the Commission for an amendment or supplement to the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus or for additional information, (iii)
    of the commencement by the Commission or by any state securities commission of any proceedings for the suspension of the qualification of any of the Shares for offering or sale in any jurisdiction or of the initiation, or the threatening, of any
    proceeding for that purpose, including, without limitation, the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto or the initiation of any proceedings for
    such purposes or the threat thereof, (iv) of the happening of any event during the Prospectus Delivery Period that in the judgment of the Company makes any statement made in the Registration Statement or the Prospectus untrue or that requires the
    making of any amendment or supplement to the Prospectus or any Permitted Free Writing Prospectus in order to make the statements therein, in the light of the circumstances in which they were made, not misleading and (v) of receipt by the Company or any
    representative of the Company of any other communication from the Commission relating to the Company, the Registration Statement, the Prospectus, any Permitted Free Writing Prospectus or any preliminary prospectus. If at any time the Commission shall
    issue any such stop order suspending the effectiveness of the Registration Statement, the Company shall use its best efforts to obtain the withdrawal of such order at the earliest possible moment. In connection with the offer and sale of the Shares
    pursuant to the Registration Statement, the Company shall use its best efforts to comply with the provisions of and make all requisite filings with the Commission pursuant to Rules&#160;424(b), 430A, 430B, 430C and 462(b) of the Rules and Regulations and to
    notify the Agents promptly of all such filings.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 16; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Executed Registration Statements.</i> The Company shall furnish to the Agents, without charge, an electronic copy of the signed Registration Statement
    and of any post-effective amendment thereto, including financial statements and schedules, and all exhibits thereto (including any document filed under the Exchange Act that is deemed to be incorporated by reference into the Prospectus).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Undertakings.</i> The Company shall comply with all the provisions of any undertakings contained or required to be contained in the Registration
    Statement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Prospectus.</i> The Company shall furnish to the Agents, without charge, as many copies of the Prospectus and any amendment or supplement thereto as the
    Agents may reasonably request (to the extent not previously delivered or filed on EDGAR) via electronic mail in &#8220;.pdf&#8221; format and, at the Agents&#8217; request, to furnish copies of the Prospectus to the Exchange and each other exchange or market on which
    sales of the Shares were or are expected to be effected, in each case, as may be required by the rules or regulations of the Exchange or such other exchange or market. The Company consents to the use of the Prospectus and any amendment or supplement
    thereto by the Agents during the Prospectus Delivery Period. If any Agent is required to deliver, under the Act (whether physically, deemed to be delivered pursuant to Rule 153 or through compliance with Rule 172 under the Act or any similar rule), a
    prospectus relating to the Shares after the nine-month period referred to in Section 10(a)(3) of the Act, or after that time a post-effective amendment to the Registration Statement is required pursuant to Item 512(a) of Regulation S-K under the Act,
    then, upon the request of such Agent, and at the Company&#8217;s own expense, the Company shall prepare and deliver to such Agent as many copies as such Agent may request of an amended Registration Statement or amended and supplemented Prospectus complying
    with Item 512(a) of Regulation S-K or Section 10(a)(3) of the Act, as the case may be.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Permitted Free Writing Prospectuses. </i>The Company represents and agrees that it has not made and, unless it obtains the prior consent of the Agents,
    shall not make, any offer relating to the Shares that would constitute a &#8220;free writing prospectus&#8221; as defined in Rule 405 of the Rules and Regulations, which is required to be retained by the Company under Rule 433 of the Rules and Regulations; <i>provided</i>
    that the prior written consent of the Agents hereto shall be deemed to have been given in respect of each of the free writing prospectuses set forth in <b><u>Schedule 3</u></b> hereto. Any such free writing prospectus consented to by the Agents is
    herein referred to as a &#8220;Permitted Free Writing Prospectus.&#8221; The Company represents and agrees that (i) it has treated and shall treat, as the case may be, each Permitted Free Writing Prospectus as a &#8220;free writing prospectus&#8221; as defined in Rule 405 of
    the Rules and Regulations and (ii) it has complied and shall comply, as the case may be, with the requirements of Rules 164 and 433 of the Act applicable to any Permitted Free Writing Prospectus, including, without limitation, in respect of timely
    filing with the Commission, legending and record keeping. The Company agrees not to take any action that would result in any Agent or the Company being required to file pursuant to Rule 433(d) under the Act a free writing prospectus prepared by or on
    behalf of such Agent that such Agent otherwise would not have been required to file thereunder.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Registration Statement Renewal Deadline. </i>If, immediately prior to the third anniversary of the initial effective date of the Registration Statement
    relating to the Shares (the &#8220;<b>Renewal Deadline</b>&#8221;), any of the Shares remain unsold by the Agents, the Company shall prior to the Renewal Deadline (i) file, if it has not already done so (subject to subsection (a) of this Section 3), a new shelf
    registration statement relating to the Shares, in a form reasonably satisfactory to the Agents, (ii) use its best efforts to cause such registration statement to be declared effective within 60 days after the Renewal Deadline (if the Company is not
    then eligible to file an automatic shelf registration statement) and (iii) take all other action necessary or appropriate to permit the public offering and sale of the Shares to continue as contemplated herein and in the expired registration statement
    relating to the Shares. References herein to the Registration Statement relating to the Shares shall include such new shelf registration statement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 17; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Notice of Inability to Use Automatic Shelf Registration Statement Form. </i>If, at any time when the Shares remain unsold by the Agents, the Company
    receives from the Commission a notice pursuant to Rule 401(g)(2) of the Rules and Regulations or otherwise ceases to be eligible to use the Registration Statement for the offer and sale of the Shares, the Company shall (i) promptly notify each Agent,
    (ii) promptly file a new registration statement or post-effective amendment to the existing Registration Statement on the proper form relating to the Shares, in a form reasonably satisfactory to each Agent and subject to subsection (a) of this Section
    3, (iii) use its best efforts to cause such registration statement or post-effective amendment to be declared effective as soon as practicable, and (iv) promptly notify each Agent upon such effectiveness. The Company shall take all other action
    necessary or appropriate to permit the public offering and sale of the Shares to continue as contemplated herein and in the Registration Statement that was the subject of the notice pursuant to Rule 401(g)(2) or for which the Company has otherwise
    become ineligible to use. References herein to the Registration Statement relating to the Shares shall include such new registration statement or post-effective amendment, as the case may be.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Filing Fees</i>. The Company agrees to pay the required Commission filing fees relating to the Shares within the time required by Rule 456(b)(1) without
    regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(k)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Compliance with Blue Sky Laws.</i> The Company shall cooperate with the Agents and counsel therefor in connection with the registration or qualification
    (or the obtaining of exemptions therefrom) of the Shares for the offering and sale under the securities or Blue Sky laws of such jurisdictions as the Agents may request, and to continue such registration or qualification in effect so long as necessary
    under such laws for the distribution of the Shares; <i>provided</i>, <i>however</i>, that in no event shall the Company be obligated to qualify to do business in any jurisdiction where it is not now so qualified or to take any action which would
    subject it to general service of process in any jurisdiction where it is not now so subject (except service of process with respect to the offering and sale of the Shares).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(l)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Delivery of Financial Statements.</i> During the period of five years commencing on the later of the date hereof and the effective date of the
    Registration Statement for the distribution of the Shares, the Company shall furnish to each Agent (to the extent not available on EDGAR) copies of such financial statements and other periodic and special reports as the Company may from time to time
    distribute generally to the holders of any class of its capital stock, and a copy of each annual or other report it shall be required to file with the Commission.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(m)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Availability of Earnings Statements.</i> The Company shall make generally available to holders of its securities and each Agent as soon as may be
    practicable but in no event later than the last day of the fifteenth full calendar month following the date hereof, an earnings statement (which need not be audited but shall be in reasonable detail) covering the period of 12 months commencing after
    the date hereof, and satisfying the provisions of Section&#160;11(a) of the Act (including Rule&#160;158 of the Rules and Regulations).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(n)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Reimbursement of Certain Expenses.</i> Whether or not any of the transactions contemplated by this Agreement are consummated or this Agreement is
    terminated, the Company shall pay, or reimburse if paid by any Agent, all costs and expenses incident to the performance of the obligations of the Company under this Agreement, including, without limitation, costs and expenses of or relating to (i) the
    preparation, printing and filing of the Registration Statement and exhibits to it, each preliminary prospectus, each Permitted Free Writing Prospectus, the Prospectus and any amendment or supplement to the Registration Statement or the Prospectus
    (including the filing fees payable to the Commission relating to the Shares within the time required by Rule 456 of the Rules and Regulations), (ii) the preparation and delivery of certificates representing the Shares, (iii) the printing of this
    Agreement, (iv) furnishing (including costs of shipping, mailing and courier) such copies of the Registration Statement, the Prospectus, any preliminary prospectus and any Permitted Free Writing Prospectus, and all amendments and supplements thereto,
    as may be requested for use in connection with the offering and sale of the Shares by the Agents, (v) the listing of the Shares on the Exchange, (vi) any filings required to be made by the Agents with FINRA, and the reasonable fees, disbursements and
    other charges of counsel for the Agents in connection therewith up to $15,000, (vii) the registration or qualification of the Shares for offer and sale under the Act and the securities or Blue Sky laws of such jurisdictions designated pursuant to
    subsection (k) of this Section 3, including the fees, disbursements and other charges of counsel to the Agents in connection therewith, and, if requested by the Agents, the preparation and printing of preliminary, supplemental and final Blue Sky or
    Legal Investment memoranda, (viii) counsel to the Company, (ix) The Depository Trust Company and any other depositary, transfer agent or registrar for the Shares, (x) the Accountants, (xi) the marketing of the offering by the Company, including,
    without limitation, all costs and expenses of commercial airline tickets, hotels, meals and other travel expenses of officers, employees, agents and other representatives of the Company, (xii) the reasonable, documented out-of-pocket fees,
    disbursements and other charges of the Agents incurred in connection with the offering and (xiii) all fees, costs and expenses for consultants used by the Company in connection with the offering.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 18; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(o)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>No Stabilization or Manipulation.</i> The Company shall not at any time, directly or indirectly (including, without limitation, through the
    subsidiaries), take any action intended to cause or result in, or which might reasonably be expected to cause or result in, or which will constitute, stabilization or manipulation, under the Act or otherwise, of the price of the shares of Common Stock
    to facilitate the sale or resale of any of the Shares.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(p)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Use of Proceeds.</i> The Company shall apply the net proceeds from the offering and sale of the Shares to be sold by the Company in the manner set forth
    in the Prospectus under &#8220;Use of Proceeds&#8221; and, except as disclosed in the Prospectus, the Company does not intend to use any of the proceeds from the sale of the Shares to repay any outstanding debt owed to the Agents or any affiliate of any Agent.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(q)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Clear Market.</i> The Company shall not offer to sell, sell, pledge, hypothecate, contract or agree to sell, purchase any option to sell, grant any
    option for the purchase of, lend, or otherwise dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or warrants or other rights to acquire shares of Common
    Stock or any other securities of the Company that are substantially similar to the Common Stock or permit the registration under the Act of any shares of the Common Stock without the prior written consent of the Agents, unless it gives the Agents at
    least three business days&#8217; prior written notice specifying the nature and date of such proposed transaction. Notwithstanding the foregoing, the Company may (i) register the offering and sale of the Shares through any Agent pursuant to this Agreement,
    (ii) issue shares of Common Stock upon the exercise of an option or warrant or the conversion of a security outstanding on the date hereof and referred to in the Prospectus, (iii) issue shares of Common Stock pursuant to agreements (individually, an &#8220;<b>Exchange

      Agreement</b>&#8221; and collectively, the &#8220;<b>Exchange Agreements</b>&#8221;), whether in existence on the date hereof or entered into subsequent to the date hereof, to exchange a principal amount of its 5.125% Senior Notes due 2029&#160;(the &#8220;<b>Senior Notes</b>,&#8221;
    and the shares of Common Stock issuable upon conversion of such Senior Notes, the &#8220;<b>Exchange Shares</b>&#8221;), plus accrued but unpaid interest, (iv) issue shares of Common Stock or options to purchase Common Stock granted pursuant to existing employee
    benefit plans of the Company, or (v) issue shares of Common Stock pursuant to any non-employee director stock plan, dividend reinvestment plan or stock purchase plan of the Company. If notice of a proposed transaction is provided by the Company
    pursuant to this subsection (q), either Agent may suspend activity of the transactions contemplated by this Agreement for such period of time as may be requested by the Company or as may be deemed appropriate by such Agent.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(r)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Stock Exchange Listing.</i> The Company shall use its best efforts to cause the Shares to be listed on the Exchange and to maintain such listing.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(s)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Additional Notices</i>. The Company shall notify each Agent immediately after it shall have received notice or obtained knowledge of any information or
    fact that would alter or affect any opinion, certificate, letter or any other document provided to the Agents pursuant to Section 4 below.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 19; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(t)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Representation Date Certificates</i>. Upon commencement of the offering of the Shares under this Agreement (and upon the recommencement of the offering
    of the Shares under this Agreement following the termination of a suspension of sales hereunder), and each time that (i) the Registration Statement or the Prospectus is amended or supplemented (other than (x) a prospectus supplement relating solely to
    the offering of securities pursuant to the Registration Statement other than the Shares or (y) an amendment or supplement effected by the filing with the Commission of any document incorporated by reference therein), (ii) there is filed with the
    Commission an Annual Report on Form 10-K or&#160;a Quarterly Report on Form 10-Q, (iii) otherwise as any Agent may reasonably request and (iv) Shares are delivered to any Agent pursuant to a Terms Agreement (such commencement date, any such recommencement
    date, if applicable, and each such date referred to in clauses (i), (ii), and (iii) and (iv) above, a &#8220;<b>Representation Date</b>&#8221;), to furnish or cause to be furnished to each Agent forthwith a certificate dated and delivered as of such date, in form
    reasonably satisfactory to the Agents, to the effect that the statements contained in the certificate(s) referred to in Section 4(c) are true and correct at the time of such commencement, recommencement, amendment, supplement or filing, as the case may
    be, as though made at and as of such time and modified as necessary to relate to the Registration Statement and the Prospectus as amended and supplemented to the time of delivery of such certificate.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(u)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Company Counsel Legal Opinions</i>. On each Representation Date, the Company shall cause to be furnished to the Agents, dated as of such date and
    addressed to each Agent, in form and substance reasonably satisfactory to each Agent, the written opinion of Gibson, Dunn &amp; Crutcher, LLP, outside counsel for the Company, as described in Section 4(d), but modified as necessary to relate to the
    Registration Statement and the Prospectus, as amended and supplemented to the time of delivery of such opinion. In lieu of delivering such an opinion for dates subsequent to the commencement of the offering of the Shares under this Agreement such
    counsel may furnish the Agents with a letter (a &#8220;<b>Reliance Letter</b>&#8221;) to the effect that each Agent may rely on a prior opinion delivered under this Section 3(u) to the same extent as if it were dated the date of such letter (except that statements
    in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented as of such subsequent date).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Comfort Letters</i>. On each Representation Date, the Company shall cause the Accountants to deliver to the Agents the comfort letter(s) described in
    Section 4(f).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(w)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Due Diligence</i>. The Company shall reasonably cooperate with any reasonable due diligence review requested by the Agents or its counsel from time to
    time in connection with the transactions contemplated hereby or any Terms Agreement, including, without limitation, (i) prior to the open of trading on each intended Purchase Date and any Time of Sale or Settlement Date, making available appropriate
    corporate officers of the Company and, upon reasonable request, representatives of the Accountants for an update on diligence matters with representatives of each Agent and its counsel and (ii) at each Representation Date or otherwise as any Agent may
    reasonably request, providing information and making available documents and appropriate corporate officers of the Company and representatives of the Accountants for one or more due diligence sessions with representatives of the Agents and its counsel.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(x)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Reservation of the Shares</i>. The Company shall reserve and keep available at all times, free of preemptive rights, Shares for the purpose of enabling
    the Company to satisfy its obligations hereunder.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(y)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Agent Trading</i>. The Company hereby consents to the Agents trading in the Common Stock for each Agent&#8217;s own account and for the account of its clients
    at the same time as sales of the Shares pursuant to this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(z)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Deemed Representations and Warranties</i>. The Company hereby agrees that each acceptance by it of an offer to purchase Shares hereunder shall be deemed
    to be (i) an affirmation to the Agents that the representations and warranties of the Company contained in or made pursuant to this Agreement are true and correct as of the date of such acceptance as though made at and as of such date and (ii) an
    undertaking that such representations and warranties will be true and correct as of the Time of Sale and the Settlement Date for the Shares relating to such acceptance as though made at and as of each of such dates (except that such representations and
    warranties shall be deemed to relate to the Registration Statement and the Prospectus as amended and supplemented to the date of such acceptance, such Time of Sale or such Settlement Date, as the case may be).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(aa)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Board Authorization</i>. Prior to delivering notice of the proposed terms of an Agency Transaction or a Principal Transaction pursuant to Section 1 (or
    at such time as otherwise agreed between the Company and the Agents), the Company shall, if applicable, have (i) obtained from its board of directors or a duly authorized subcommittee thereof all necessary corporate authority for the sale of the Shares
    pursuant to the relevant Agency Transaction or Principal Transaction, as the case may be, and (ii) provided to each Agent a copy of the relevant board resolutions or other authority. In lieu of delivering such resolutions for dates subsequent to the
    commencement of the offering of the Shares under this Agreement, the Company may deliver an officer&#8217;s certificate indicating that any such previously-delivered board resolutions or authority remain in full force and effect.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 20; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(bb)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Offer to Refuse to Purchase</i>. If to the knowledge of the Company any condition set forth in Section 4(a) of this Agreement shall not have been
    satisfied on the applicable Settlement Date, the Company shall offer to any person who has agreed to purchase Shares from the Company as the result of an offer to purchase solicited by an Agent the right to refuse to purchase and pay for such Shares.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(cc)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Exchange Act Reports</i>. The Company shall, subject to subsection (a) of this Section 3, (i)&#160;timely file all reports and any definitive proxy or
    information statements required to be filed by the Commission pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act subsequent to the date of the Prospectus and for the duration of the Prospectus Delivery Period and (ii)&#160;disclose in its
    quarterly reports on Form 10-Q and in its annual report on Form 10-K a summary detailing, for the relevant reporting period, the number of Shares sold through or to the Agents under this Agreement, the net proceeds received by the Company from such
    sales and the compensation paid by the Company to the Agents with respect to such sales. In lieu of compliance with the requirement set forth in clause (ii) of the immediately preceding sentence, the Company may prepare a prospectus supplement with
    such summary information and, at least once a quarter and subject to subsection (a) of this Section 3, file such prospectus supplement pursuant to Rule 424(b) under the Act (and within the time periods required by Rule 424(b) and Rule 430A, 430B or
    430C under the Act).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(dd)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Conversion of Senior Notes</i>. In the event that the Company has entered into any Exchange Agreements for an aggregate number of Exchange Shares that
    under the Exchange Act would be required to be disclosed by the Company in a current report on From 8-K or a quarterly report on From 10-Q, the Company shall timely disclose such aggregate number of Exchange Shares when and as required to do so under
    the Exchange Act, prior to commencing any further transactions contemplated by this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(ee)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Recognition of the U.S. Special Resolution Regimes</i>. In the event that an Agent is a Covered Entity and becomes subject to a proceeding under a U.S.
    Special Resolution Regime, the transfer from such Agent of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime
    (defined below) if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. In the event that any Agent that is a Covered Entity or a BHC Act Affiliate of an Agent becomes
    subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Agent are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S.
    Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. &#8220;<b>BHC Act Affiliate</b>&#8221; shall mean &#8220;affiliate&#8221; as defined in, and shall be interpreted in accordance with, 12 U.S.C. &#167;
    1841(k). &#8220;<b>Covered Entity</b>&#8221; shall mean any of the following: (i) a &#8220;covered entity&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b), (ii) a &#8220;covered bank&#8221; as that term is defined in, and interpreted in
    accordance with, 12 C.F.R. &#167; 47.3(b) or (iii) a &#8220;covered FSI&#8221; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b). &#8220;<b>Default Right</b>&#8221; shall mean default right as defined and interpreted in accordance with, 12 C.F.R.
    &#167;&#167; 252.81, 47.2 or 382.1, as applicable. &#8220;<b>U.S. Special Resolution Regime</b>&#8221; shall mean each of (i) the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii) Title II of the Dodd-Frank Wall Street Reform and Consumer
    Protection Act and the regulations promulgated thereunder.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">4.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Conditions of the Obligations of the Agents</u>. The obligations of each Agent hereunder are subject to (i) the accuracy of the representations and
    warranties of the Company on the date hereof, on each Representation Date and as of each Time of Sale and Settlement Date, (ii) the performance of the Company of its obligations hereunder and (iii) the following additional conditions:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>No Stop Orders, Requests for Information.</i> (i) No stop order suspending the effectiveness of the Registration Statement shall have been issued and no
    proceedings for that purpose shall be pending or are, to the knowledge of the Company, threatened by the Commission, and the Company shall not have received from the Commission any notice pursuant to Rule 401(g)(2) of the Act objecting to use of the
    automatic shelf registration statement form (ii) no order suspending the qualification or registration of the Shares under the securities or Blue Sky laws of any jurisdiction shall be in effect and no proceeding for such purpose shall be pending before
    or threatened or contemplated by the authorities of any such jurisdiction and (iii) any request for additional information on the part of the staff of the Commission or any such authorities shall have been complied with to the satisfaction of the staff
    of the Commission or such authorities and (iv) after the date hereof no amendment or supplement to the Registration Statement or the Prospectus (other than (x) a prospectus supplement relating solely to the offering of securities pursuant to the
    Registration Statement other than the Shares or (y) an amendment or supplement effected by the filing with the Commission of any document incorporated by reference therein) shall have been filed unless a copy thereof was first submitted to the Agents
    and each Agent did not reasonably object thereto within a reasonable time.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 21; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>No Material Adverse Changes.</i> Since the date of the most recent financial statements of the Company included or incorporated by reference in the
    Registration Statement and the Prospectus, except as described in the Registration Statement and the Prospectus, there shall not have been a Material Adverse Change.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Officer&#8217;s Certificates.</i> The Agents shall have received, on each Representation Date, one or more accurate certificates, dated such date and signed
    by an executive officer of the Company, in form and substance reasonably satisfactory to each Agent, to the effect set forth in clauses (a) and (b) above and to the effect that:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;each signer of such certificate has carefully examined the Registration Statement, the Prospectus (including any documents filed under the Exchange Act and
    deemed to be incorporated by reference into the Prospectus) and each Permitted Free Writing Prospectus, if any;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;as of such date and as of each Time of Sale subsequent to the immediately preceding Representation Date, if any, neither the Registration Statement, the
    Prospectus nor any Permitted Free Writing Prospectus contained any untrue statement of a material fact or omitted to state any material fact necessary to make the statements therein, in the light of the circumstances under which they were made, not
    misleading;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;each of the representations and warranties of the Company contained in this Agreement are, as of such date and each Time of Sale subsequent to the
    immediately preceding Representation Date, if any, true and correct; and</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;each of the covenants and agreements required herein to be performed by the Company on or prior to such date has been duly, timely and fully performed and
    each condition herein required to be complied with by the Company on or prior to such date has been duly, timely and fully complied with.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Opinions of Counsel to the Company.</i> The Agents shall have received, on each Representation Date, an opinion and negative assurance letter of Gibson,
    Dunn &amp; Crutcher, LLP, outside counsel for the Company, each dated such date and addressed to each Agent, in form and substance satisfactory to each Agent.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Opinion of Counsel to the Agents.</i> The Agent shall have received, on each Representation Date, a negative assurance letter of Dorsey &amp; Whitney
    LLP, outside counsel for the Agents, dated such date and addressed to each Agent, in form and substance reasonably satisfactory to each Agent.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Accountants&#8217; Comfort Letter.</i> The Agents shall have received, on each Representation Date, letters dated such date and addressed to each Agent, in
    form and substance reasonably satisfactory to each Agent, (i) confirming that the Accountants are an independent registered public accounting firm within the meaning of the Act, the Exchange Act and the PCAOB, (ii) stating, as of such date, the
    conclusions and information of the type ordinarily included in accountants&#8217; &#8220;comfort letters&#8221; to sales agents in connection with registered &#8220;at the market&#8221; offerings with respect to the audited and unaudited financial statements and certain other
    financial information contained or incorporated by reference in the Registration Statement and the Prospectus (the first such letter, the &#8220;Initial Comfort Letter&#8221;) and (iii) in the case of any such letter after the Initial Comfort Letter, updating the
    Initial Comfort Letter with any information that would have ordinarily been included in the Initial Comfort Letter had it been given on such date and modified as necessary to relate to the Registration Statement, the Prospectus or any Permitted Free
    Writing Prospectus, as amended or supplemented to the date of such letter.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 22; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Due Diligence</i>. The Company shall have complied with all of its due diligence obligations required pursuant to Section 3(w).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Compliance with Blue Sky Laws.</i> The Shares shall be qualified for sale in such states and jurisdictions as the Agents may reasonably request, and
    each such qualification shall be in effect and not subject to any stop order or other proceeding on the relevant Representation Date.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Stock Exchange Listing.</i> The Shares shall have been duly authorized for listing or quotation on the Exchange, subject only to notice of issuance at
    or prior to the applicable Settlement Date.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Regulation M</i>. The Common Stock shall be an &#8220;actively-traded security&#8221; excepted from the requirements of Rule 101 of Regulation M under the Exchange
    Act by subsection&#160;(c)(1) of such rule.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">5.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Indemnification</u>.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Indemnification of the Agents.</i> The Company shall indemnify and hold harmless each Agent, the directors, officers, employees, counsel, affiliates and
    agents of each Agent and each person, if any, who controls each Agent within the meaning of Section&#160;15 of the Act or Section&#160;20 of the Exchange Act from and against any and all losses, claims, liabilities, expenses and damages (including, without
    limitation, any and all investigative, legal and other expenses reasonably incurred in connection with any claim asserted), to which they, or any of them, may become subject under the Act, the Exchange Act or other federal or state statutory law or
    regulation, at common law or otherwise, insofar as such losses, claims, liabilities, expenses or damages arise out of or are based on (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or
    any amendment thereto), including any information deemed to be a part thereof pursuant to Rules 430A, 430B or 430C, as applicable, including all documents incorporated therein by reference, or the omission or alleged omission therefrom of a material
    fact required to be stated therein or necessary to make the statements therein not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in any Permitted Free Writing Prospectus or the Prospectus (or any
    amendment or supplement thereto) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading or (iii) any untrue
    statement or alleged untrue statement of a material fact contained in any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Shares, including any roadshow or
    investor presentations made to investors by the Company (whether in person or electronically) or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under
    which they were made, not misleading; <i>provided</i>, <i>however</i>, that the Company shall not be liable to the extent that such loss, claim, liability, expense or damage arises from the sale of the Shares in the public offering to any person by
    each Agent and is based on an untrue statement or omission or alleged untrue statement or omission made in reliance on and in conformity with information relating to each Agent furnished in writing to the Company by such Agent expressly for inclusion
    in the Registration Statement, the Prospectus or any Permitted Free Writing Prospectus, which constitutes the information set forth in <b><u>Schedule 2</u></b> hereto. This indemnity agreement will be in addition to any liability that the Company
    might otherwise have.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Indemnification of the Company.</i> An Agent shall indemnify and hold harmless the Company, the directors, officers, employees, counsel and agents and
    each person, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20 of the Exchange Act to the same extent as the foregoing indemnity from the Company to such Agent, but only insofar as losses, claims, liabilities,
    expenses or damages arise out of or are based on any untrue statement or omission or alleged untrue statement or omission made in reliance on and in conformity with information relating to such Agent furnished in writing to the Company by such Agent
    expressly for inclusion in the Registration Statement, any Permitted Free Writing Prospectus or the Prospectus. This indemnity will be in addition to any liability that such Agent might otherwise have.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 23; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Indemnification Procedures.</i> Any party that proposes to assert the right to be indemnified under this Section 5 shall, promptly after receipt of
    notice of commencement of any action against such party in respect of which a claim is to be made against an indemnifying party or parties under this Section 5, notify each such indemnifying party of the commencement of such action, enclosing a copy of
    all papers served, but the omission so to notify such indemnifying party shall not relieve the indemnifying party from any liability that it may have to any indemnified party under the foregoing provisions of this Section&#160;5 unless, and only to the
    extent that, such omission results in the forfeiture of substantive rights or defenses by the indemnifying party. If any such action is brought against any indemnified party and it notifies the indemnifying party of its commencement, the indemnifying
    party will be entitled to participate in and, to the extent that it elects by delivering written notice to the indemnified party promptly after receiving notice of the commencement of the action from the indemnified party, jointly with any other
    indemnifying party similarly notified, to assume the defense of the action, with counsel satisfactory to the indemnified party, and after notice from the indemnifying party to the indemnified party of its election to assume the defense, the
    indemnifying party will not be liable to the indemnified party for any legal or other expenses except as provided below and except for the reasonable costs of investigation subsequently incurred by the indemnified party in connection with the defense.
    The indemnified party will have the right to employ its own counsel in any such action, but the fees, expenses and other charges of such counsel will be at the expense of such indemnified party unless (i) the employment of counsel by the indemnified
    party has been authorized in writing by the indemnifying party, (ii) the indemnified party has reasonably concluded (based on advice of counsel) that there may be legal defenses available to it or other indemnified parties that are different from or in
    addition to those available to the indemnifying party, (iii) a conflict or potential conflict exists (based on advice of counsel to the indemnified party) between the indemnified party and the indemnifying party (in which case the indemnifying party
    shall not have the right to direct the defense of such action on behalf of the indemnified party) or (iv) the indemnifying party has not in fact employed counsel to assume the defense of such action within a reasonable time after receiving notice of
    the commencement of the action, in each of which cases the reasonable fees, disbursements and other charges of counsel shall be at the expense of the indemnifying party or parties. It is understood that the indemnifying party or parties shall not, in
    connection with any proceeding or related proceedings in the same jurisdiction, be liable for the reasonable fees, disbursements and other charges of more than one separate firm admitted to practice in such jurisdiction at any one time for all such
    indemnified party or parties; provided that, for the purposes hereof, each state, province or similar political subdivision within a country will be considered a separate jurisdiction. All such fees, disbursements and other charges shall be reimbursed
    by the indemnifying party promptly as they are incurred. An indemnifying party shall not be liable for any settlement of any action or claim effected without its written consent (which consent will not be unreasonably withheld or delayed). No
    indemnifying party shall, without the prior written consent of each indemnified party, settle or compromise or consent to the entry of any judgment in any pending or threatened claim, action or proceeding relating to the matters contemplated by this
    Section 5 (whether or not any indemnified party is a party thereto), unless such settlement, compromise or consent (i) includes an unconditional release of each indemnified party from all liability arising or that may arise out of such claim, action or
    proceeding and (ii) does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any indemnified party. Notwithstanding the foregoing, if at any time an indemnified party shall have requested an
    indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by this Section 5(c), the indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without its written consent
    if (i) such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall have received notice of the terms of such settlement at least 30 days prior to such
    settlement being entered into and (iii) such indemnifying party shall not have reimbursed such indemnified party in accordance with such request prior to the date of such settlement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 24; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Contribution.</i> In order to provide for just and equitable contribution in circumstances in which the indemnification provided for in the foregoing
    paragraphs of this Section 5 is applicable in accordance with its terms but for any reason is held to be unavailable from the Company or an Agent, the Company and such Agent shall contribute to the total losses, claims, liabilities, expenses and
    damages (including, without limitation, any investigative, legal and other expenses reasonably incurred in connection with and any amount paid in settlement of, any action, suit or proceeding or any claim asserted, but after deducting any contribution
    received by the Company from persons other than such Agent, such as persons who control the Company within the meaning of the Act, officers of the Company who signed the Registration Statement and directors of the Company, who also may be liable for
    contribution) to which the Company and such Agent may be subject in such proportion as shall be appropriate to reflect the relative benefits received by the Company on the one hand and an Agent on the other hand. The relative benefits received by the
    Company on the one hand and an Agent on the other hand shall be deemed to be in the same proportion as the total net proceeds from the offering (before deducting expenses) received by the Company bear to the sum of (i) the total compensation to such
    Agent pursuant to Section 1(a)(vii) (in the case of one or more Agency Transactions hereunder) and (ii) the underwriting discounts and commissions received by such Agent as set forth in the table on the cover page of the Prospectus (in the case of one
    or more Principal Transactions pursuant to Terms Agreements). If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the allocation of contribution shall be made in such proportion as is appropriate to
    reflect not only the relative benefits referred to in the foregoing sentence but also the relative fault of the Company, on the one hand, and such Agent, on the other hand, with respect to the statements or omissions which resulted in such loss, claim,
    liability, expense or damage, or action in respect thereof, as well as any other relevant equitable considerations with respect to such offering. Such relative fault shall be determined by reference to whether the untrue or alleged untrue statement of
    a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or an Agent, the intent of the parties and their relative knowledge, access to information and opportunity to correct or prevent
    such statement or omission. The amount paid or payable by an indemnified party as a result of the loss, claim, liability, expense or damage, or action in respect thereof, referred to above in this subsection (d) shall be deemed to include, for purpose
    of this subsection (d), any legal or other expenses reasonably incurred by such indemnified party in connection with investigating or defending any such action or claim. Notwithstanding the provisions of this subsection (d), no Agent shall be required
    to contribute any amount in excess of the sum of (i) the total compensation to such Agent pursuant to Section 1(a)(vii) (in the case of one or more Agency Transactions hereunder) and (ii) the underwriting discounts and commissions received by such
    Agent as set forth in the table on the cover page of the Prospectus (in the case of one or more Principal Transactions pursuant to Terms Agreements), and no person found guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
    Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. For purposes of this subsection (d), any person who controls a party to this Agreement within the meaning of the Act will have the same
    rights to contribution as that party, and each officer of the Company who signed the Registration Statement will have the same rights to contribution as the Company, subject in each case to the provisions hereof. Any party entitled to contribution,
    promptly after receipt of notice of commencement of any action against such party in respect of which a claim for contribution may be made under this subsection (d), will notify any such party from whom contribution may be sought, but the omission so
    to notify will not relieve the party from whom contribution may be sought from any other obligation it may have under this subsection (d). No party will be liable for contribution with respect to any action or claim settled without its written consent
    (which consent will not be unreasonably withheld).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Survival.</i> The obligations of the Company under this Section 5 shall be in addition to any liability which the Company may otherwise have and shall
    extend, upon the same terms and conditions, to any affiliate of an Agent and each person, if any, who controls such Agent or any such affiliate within the meaning of the Act; and the obligations of each Agent under this Section 5 shall be in addition
    to any liability which it may otherwise have and shall extend, upon the same terms and conditions, to each officer and director of the Company and to each person, if any, who controls the Company within the meaning of the Act. The indemnity and
    contribution agreements contained in this Section 5 and the representations and warranties of the Company and each Agent contained in this Agreement shall remain operative and in full force and effect regardless of (i) any investigation made by or on
    behalf of the Company or an Agent, (ii) acceptance of any of the Shares and payment therefor or (iii) any termination of this Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">6.&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Termination</u>.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;The Company may terminate this Agreement in its sole discretion at any time upon giving prior written notice to the Agents. Any such termination shall be
    without liability of any party to the other party, except that (i) with respect to any pending sale, the obligations of the Company, including, without limitation, in respect of compensation of the Agents, shall remain in full force and effect
    notwithstanding such termination; and (ii) the provisions of Sections 2, 3(n), 5, 7(c), 7(e) and 7(h) of this Agreement shall remain in full force and effect notwithstanding such termination. In the case of any sale by the Company pursuant to a Terms
    Agreement, the obligations of the Company pursuant to such Terms Agreement (including the terms of this Agreement incorporated by reference therein) may not be terminated by the Company without the prior written consent of the Agents.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 25; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any Agent may terminate this Agreement as to itself in its sole discretion at any time upon giving prior written notice to the Company and the other Agent.
    Any such termination shall be without liability of any party to the other party, except that (i) with respect to any pending sale, the obligations of the Company, including, without limitation, in respect of compensation of the terminating Agent, shall
    remain in full force and effect notwithstanding such termination; and (ii) the provisions of Sections 2, 3(n), 5, 7(c), 7(e) and 7(h) of this Agreement shall remain in full force and effect notwithstanding such termination. In the case of any purchase
    by an Agent pursuant to a Terms Agreement, such Agent may, by written notice to the Company, terminate its obligations pursuant to such Terms Agreement at any time prior to or on the Settlement Date if, since the time of execution of the Terms
    Agreement or the respective dates as of which information is given in the Registration Statement and the Prospectus:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;trading of the Common Stock shall have been suspended on the Exchange;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;trading generally shall have been suspended or limited on or by, as the case may be, any &#8220;national securities exchange&#8221; (as defined in the Exchange Act),
    or minimum or maximum prices shall have been generally established on any such exchange, or additional material governmental restrictions, not in force on the date of this Agreement, shall have been imposed upon trading in securities generally by any
    such exchange or by order of the Commission or any court or other governmental authority;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(iii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;a general banking moratorium shall have been declared by federal or New York authorities or a material disruption has occurred in commercial banking or
    securities settlement or clearance services in the United States;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(iv)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;the United States shall have become engaged in new hostilities, there shall have been an escalation in hostilities involving the United States or there
    shall have been a declaration of a national emergency or war by the United States or there shall have occurred such a material adverse change in general economic, political or financial conditions, including, without limitation, as a result of
    terrorist activities after the date hereof (or the effect of international conditions on the financial markets in the United States shall be such), or any other national calamity or crisis shall have occurred, the effect of any of which is such as to
    make it impracticable or inadvisable to market the Shares on the terms and in the manner contemplated by the Prospectus; or</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(v)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if the Company or any of the subsidiaries shall have sustained a loss material or substantial to the Company or any of the subsidiaries by reason of flood,
    fire, accident, hurricane, earthquake, theft, sabotage, or other calamity or malicious act, whether or not such loss shall have been insured, the effect of any of which is such as to make it impracticable or inadvisable to market the Shares on the
    terms and in the manner contemplated by the Prospectus; or</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 95pt">(vi)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;if there shall have been a Material Adverse Change.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;This Agreement shall remain in full force and effect until the earliest to occur of (A) termination of this Agreement pursuant to subsection (a) or (b)
    above or otherwise by mutual written agreement of the parties, and (B) such date that the aggregate gross sales proceeds of the Shares sold pursuant to this Agreement (including, without limitation, one or more Terms Agreements pursuant hereto) equals
    the Maximum Amount, in each case except that (i) with respect to any pending sale, the obligations of the Company, including, without limitation, in respect of compensation of an Agent, shall remain in full force and effect notwithstanding such
    termination; and (ii) the provisions of Sections 2, 3(n), 5, 7(c), 7(e) and 7(h) of this Agreement shall remain in full force and effect notwithstanding such termination.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Any termination of this Agreement shall be effective on the date specified in the notice of termination; <i>provided</i> that such termination shall not
    be effective until the close of business on the date of receipt of such notice by the Agents or the Company, as the case may be. If such termination shall occur prior to the Settlement Date for any sale of Shares, such sale shall settle in accordance
    with the provisions of Section 1 (in the case of an Agency Transaction) or in accordance with the relevant Terms Agreement (in the case of a Principal Transaction).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>
  <!-- Field: Page; Sequence: 26; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">7.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<u>Miscellaneous</u>.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(a)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Notices. </i>Notice given pursuant to any of the provisions of this Agreement shall be in writing and, unless otherwise specified, shall be mailed,
    hand delivered or telecopied (i) if to the Company, at the office of the Company, 200 South Wacker Drive, Suite 2100, Chicago, Illinois 60606 (FAX: (312) 489-5899), Attention: General Counsel, or (ii) if to (A) BMO, at the offices of BMO Capital
    Markets Corp., 151 W 42<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd </sup>Street, New York, New York 10036, Attention: Equity Capital Markets desk, with a copy to the Legal Department, (B) RBC, at the offices of RBC
    Capital Markets, LLC, Attention: Equity Syndicate, 200 Vesey Street, 8th Floor, Brookfield Place New York, New York, New York 10281, Attention: TJ Opladen (email: tj.opladen@rbccm.com) and (C) BofA, at the offices of BofA Securities Inc., One Bryant
    Park, New York, New York 10036, Attention: ATM Execution (email: dg.atm_execution@bofa.com), with a copy to ECM Legal (email: dg.ecm_legal@bofa.com). Any such notice shall be effective only upon receipt. Any notice under Section 5 may be made by
    telecopy or telephone, but if so made shall be subsequently confirmed in writing (which may include, in the case of the Agents, electronic mail to any Authorized Company Representative).</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(b)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;[Intentionally Omitted]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(c)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Survival of Representations and Warranties.</i> All representations, warranties and agreements of the Company and the Agents contained herein or in
    certificates or other instruments delivered pursuant hereto (including, without limitation, any Terms Agreement) shall remain operative and in full force and effect, as of their respective dates, regardless of any investigation made by or on behalf of
    the Company or the Agents or any of their controlling persons and shall survive delivery of and payment for the Shares hereunder.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(d)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Disclaimer of Fiduciary Relationship</i>. The Company acknowledges and agrees that (i) the purchase and sale of the Shares pursuant to this Agreement,
    including the determination of the terms of the offering and any related discounts and commissions, is an arm&#8217;s-length commercial transaction between the Company, on the one hand, and each Agent, on the other hand, (ii) in connection with the offering
    contemplated by this Agreement and the process leading to such transaction, each Agent owes no fiduciary duties to the Company or its securityholders, creditors, employees or any other party, (iii) no Agent has assumed nor will it assume any advisory
    or fiduciary responsibility in favor of the Company with respect to the offering of the Shares contemplated by this Agreement or the process leading thereto (irrespective of whether an Agent or its affiliates has advised or is currently advising the
    Company on other matters) and no Agent has any obligation to the Company with respect to the offering of the Shares contemplated by this Agreement except the obligations expressly set forth in this Agreement, (iv) an Agent and its affiliates may be
    engaged in a broad range of transactions that involve interests that differ from those of the Company and (v) no Agent has provided any legal, accounting, regulatory or tax advice with respect to the offering contemplated by this Agreement and the
    Company has consulted its own legal, accounting, regulatory and tax advisors to the extent it deemed appropriate.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(e)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Governing Law.</i> THIS AGREEMENT AND EACH TERMS AGREEMENT, AND ANY DISPUTE, CLAIM OR CONTROVERSY ARISING UNDER OR RELATED TO THIS AGREEMENT OR SUCH
    TERMS AGREEMENT, SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK APPLICABLE TO AGREEMENTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE. Each party hereto hereby irrevocably submits for purposes of any
    action arising from this Agreement or any Terms Agreement brought by the other party hereto to the jurisdiction of the courts of New York State located in the Borough of Manhattan and the U.S. District Court for the Southern District of New York.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(f)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Counterparts</i>. This Agreement and each Terms Agreement may be signed in two or more counterparts with the same effect as if the signatures thereto
    and hereto were upon the same instrument. Counterparts may be delivered via facsimile, electronic mail (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act, the Electronic Signatures and
    Records Act or other applicable law, e.g., www.docusign.com) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all purposes.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <!-- Field: Page; Sequence: 27; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(g)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Survival of Provisions Upon Invalidity of Any Single Provision.</i> In case any provision in this Agreement or any Terms Agreement shall be invalid,
    illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(h)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Waiver of Jury Trial.</i> Each of the Company and each Agent hereby irrevocably waives any right it may have to a trial by jury in respect of any claim
    based upon or arising out of this Agreement, any Terms Agreement or the transactions contemplated hereby or thereby.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(i)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Titles and Subtitles.</i> The titles of the sections and subsections of this Agreement and any Terms Agreement are for convenience and reference only
    and are not to be considered in construing this Agreement or such Terms Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 1in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 60pt">(j)&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<i>Entire Agreement.</i> Other than the terms set forth in each Agency Transaction Notice delivered hereunder and each Terms Agreement executed and
    delivered pursuant hereto, this Agreement embodies the entire agreement and understanding between the parties hereto and supersedes all prior agreements and understandings relating to the subject matter hereof. Neither this Agreement nor any Terms
    Agreement may be amended or otherwise modified or any provision hereof waived except by an instrument in writing signed by the Agents and the Company.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[<i>Signature page follows</i>]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <!-- Field: Page; Sequence: 28; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Please confirm that the foregoing correctly sets forth the agreement between the Company and each Agent.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="3"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="3">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="3"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COEUR MINING, INC.</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td>&#160;</td>
        <td colspan="2">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="border-bottom: Black 1pt solid" colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Mitchell J. Krebs</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="width: 50%">&#160;</td>
        <td style="width: 4%"></td>
        <td style="width: 6%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name: </font></td>
        <td style="width: 40%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mitchell J. Krebs</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td></td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </font></td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">President and Chief Executive Officer</font></td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 276pt">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted and agreed as of</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">the date first above written:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <font style="font-weight: normal; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;"> </font>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td colspan="4"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">BMO CAPITAL MARKETS CORP.</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td colspan="3">&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By</font></td>
        <td style="border-bottom: Black 1pt solid" colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Brad Pavelka</font></td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="width: 4%"></td>
        <td style="width: 6%">Name:</td>
        <td style="width: 40%"> Brad Pavelka</td>
        <td style="width: 50%">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td></td>
        <td>Title:</td>
        <td>Managing Director</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td colspan="4">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td colspan="3"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase">RBC CAPITAL MARKETS, LLC</font></td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2">&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="border-bottom: Black 1pt solid" colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Michael Ventura</font></td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td></td>
        <td>Name:</td>
        <td>Michael Ventura</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td></td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title: </font></td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Managing Director</font></td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2">&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td colspan="3"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">BOFA SECURITIES, INC.</font></td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td colspan="3">&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="border-bottom: Black 1pt solid" colspan="2">
          <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: normal; font-style: normal; font-variant: normal; text-transform: none;">/s/ Christine Roemer</div>
        </td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td></td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</font></td>
        <td style="font-weight: normal; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-style: normal; font-variant: normal; text-transform: none;">
          <div style="text-align: left; color: rgb(0, 0, 0);">Christine Roemer</div>
        </td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td></td>
        <td>Title:</td>
        <td style="font-size: 10pt; color: rgb(0, 0, 0);">
          <div style="text-align: left; font-family: 'Times New Roman',Times,serif;">Managing Director</div>
        </td>
        <td>&#160;</td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
  <!-- Field: Page; Sequence: 29; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">SCHEDULE 1</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">AUTHORIZED COMPANY REPRESENTATIVES</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left">1.</td>
        <td>Thomas S. Whelan, Senior Vice President and Chief Financial Officer</td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">

      <tr style="vertical-align: top; text-align: justify">
        <td style="width: 0in"></td>
        <td style="width: 0.5in; text-align: left">2.</td>
        <td>Anne Beckelheimer, Vice President, Tax and Treasurer</td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>
  <!-- Field: Page; Sequence: 30; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">SCHEDULE 2</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">INFORMATION SUPPLIED BY AGENTS</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">Each Agent&#8217;s name and the statement that such Agent will not engage in any transactions that stabilize the price of the Common Stock appearing in the last sentence of
    the first paragraph under the caption &#8220;Plan of Distribution&#8221; in the Prospectus Supplement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>
  <!-- Field: Page; Sequence: 31; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">SCHEDULE 3</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">ISSUER FREE WRITING PROSPECTUSES</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">None.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&#160;</p>
  <!-- Field: Page; Sequence: 32; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">SCHEDULE 2(cc)</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">Technical Reports</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">

      <tr style="vertical-align: bottom; background-color: White">
        <td style="border-bottom: Black 1pt solid; padding-top: 0pt; padding-right: 0pt; padding-left: 0pt; width: 80%; text-indent: 0pt">Mine</td>
        <td style="padding-bottom: 1pt; width: 1%">&#160;</td>
        <td style="border-bottom: Black 1pt solid; width: 19%; text-align: center; padding-left: 5.4pt">Technical Report <br>
          Filing Date</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="padding: 0pt; text-align: left; text-indent: 0pt">Palmarejo Operations, Mexico, Technical Report Summary, effective December 31, 2021</td>
        <td>&#160;</td>
        <td style="text-align: center; padding-left: 5.4pt">February 16, 2022</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="padding: 0pt; text-align: left; text-indent: 0pt">Rochester Operations, Nevada, Technical Report Summary, effective December 31, 2021 <br>
        </td>
        <td>&#160;</td>
        <td style="text-align: center; padding-left: 5.4pt">February 16, 2022</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
        <td style="padding: 0pt; text-align: left; text-indent: 0pt">Kensington Gold Operations, Alaska, Technical Report Summary, effective December 31, 2021</td>
        <td>&#160;</td>
        <td style="text-align: center; padding-left: 5.4pt">February 16, 2022</td>
      </tr>
      <tr style="vertical-align: bottom; background-color: White">
        <td style="padding: 0pt; text-align: left; text-indent: 0pt">Wharf Operations, South Dakota, Technical Report Summary, effective December 31, 2021</td>
        <td>&#160;</td>
        <td style="text-align: center; padding-left: 5.4pt">February 16, 2022</td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <!-- Field: Page; Sequence: 33; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">EXHIBIT A</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[Coeur Mining, Inc. Letterhead]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[_______], 20[__]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BMO Capital Markets Corp.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">151 W 42<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> Street</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10036</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RBC Capital Markets, LLC</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">200 Vesey Street, 8th Floor</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brookfield Place New York</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10281</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BofA Securities, Inc.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">One Bryant Park</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">New York, New York 10036</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">VIA EMAIL</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><u>AGENCY TRANSACTION NOTICE</u></b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The purpose of this Agency Transaction Notice is to propose certain terms of the Agency Transaction entered into with [BMO Capital Markets Corp.][RBC Capital Markets,
    LLC][BofA Securities, Inc.] under, and pursuant to, that certain ATM Equity Offering Sales Agreement between the Company and BMO Capital Markets Corp., RBC Capital Markets, LLC and BofA Securities, Inc. dated August 10, 2023 (the &#8220;Agreement&#8221;). Please
    indicate your acceptance of the proposed terms below. Upon acceptance, the particular Agency Transaction to which this Agency Transaction Notice relates shall supplement, form a part of, and be subject to, the Agreement. Capitalized terms used but not
    otherwise defined herein shall have the meanings ascribed to them in the Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The terms of the particular Agency Transaction to which this Agency Transaction Notice relates are as follows:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-indent: -3.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-indent: -3.5in">Trading Day(s) on which Shares may be Sold: [_______], 20[__], [_______], 20[__] . . . [_______], 20[__]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-indent: -3.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-indent: -3.5in">Maximum Number of Shares</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-indent: -3.5in">to be Sold in the Aggregate: [_______]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-indent: -3.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-indent: -3.5in">Maximum Number of Shares</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-indent: -3.5in">to be Sold on each Trading Day: [_______]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-indent: -3.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4in; text-indent: -3.5in">Floor Price: USD[__.__]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<i>Remainder of Page Intentionally Blank</i>]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&#160;</p>
  <!-- Field: Page; Sequence: 34; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COEUR MINING, INC.</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td colspan="2">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td style="width: 50%">&#160;</td>
        <td style="width: 6%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="border-bottom: Black 1pt solid; width: 44%">&#160;&#160;&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</font></td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td>&#160;</td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</font></td>
        <td>&#160;</td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted and agreed as of<br>
    the date first above written:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">[BMO Capital MarketS CORP.]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">[RBC Capital Markets, llc]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">[BOFA SECURITIES, INC.]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td style="width: 6%"><font style="font-size: 10pt">By:</font></td>
        <td style="border-bottom: Black 1pt solid; width: 44%">&#160;</td>
        <td style="width: 50%">&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td><font style="font-size: 10pt">Name:</font></td>
        <td>&#160;</td>
        <td>&#160;</td>
      </tr>
      <tr style="vertical-align: top">
        <td><font style="font-size: 10pt">Title:</font></td>
        <td>&#160;</td>
        <td>&#160;</td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <!-- Field: Page; Sequence: 35; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right; text-indent: 0.5in">EXHIBIT B</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">COEUR MINING, INC.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Common Stock</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TERMS AGREEMENT</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">[_______], 20[__]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BMO Capital Markets Corp.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">151 W 42<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">nd</sup> Street</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, NY 10036</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">RBC Capital Markets, LLC</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">200 Vesey Street, 8th Floor</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brookfield Place New York</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">New York, New York 10281</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">BofA Securities, Inc.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">One Bryant Park</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">New York, New York 10036</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Coeur Mining, Inc., a Delaware corporation (the &#8220;Company&#8221;), proposes, subject to the terms and conditions stated herein, in Schedule hereto and in the ATM Equity
    Offering Sales Agreement, dated August 10, 2023 (the &#8220;Sales Agreement&#8221;), between the Company and BMO Capital Markets Corp. (&#8220;BMO&#8221;), RBC Capital Markets, LLC (&#8220;RBC&#8221;) and BofA Securities, Inc. (&#8220;BofA&#8221;), to issue and sell to [BMO][RBC][BofA] [_______]
    shares of the Company&#8217;s common stock, par value $[_.__] per share (the &#8220;Purchased Shares&#8221;)[, and, solely for the purpose of covering over-allotments, to grant to [BMO][RBC][BofA] the option to purchase an additional [_______] shares of such common
    stock (the &#8220;Additional Shares&#8221;)]. Capitalized terms used but not otherwise defined herein shall have the meanings ascribed to them in the Agreement.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">[BMO][RBC][BofA] shall have the right to purchase from the Company all or a portion of the Additional Shares as may be necessary to cover over-allotments made in
    connection with the offering of the Purchased Shares at the same purchase price per share to be paid by [BMO][RBC][BofA] to the Company for the Purchased Shares. This option may be exercised by [BMO][RBC][BofA] at any time (but not more than once) on
    or before the thirtieth day following the date of this Terms Agreement, by written notice to the Company. Such notice shall set forth the aggregate number of Additional Shares as to which the option is being exercised, and the date and time when the
    Additional Shares are to be delivered (such date, the &#8220;Option Settlement Date&#8221;); <i>provided</i>, <i>however</i>, that the Option Settlement Date shall not be earlier than the Settlement Date (as set forth in the Schedule hereto) nor earlier than the
    second business day after the date on which the option shall have been exercised nor later than the fifth business day after the date on which the option shall have been exercised. Payment of the purchase price for the Additional Shares shall be made
    at the Option Settlement Date in the same manner and at the same office as the payment for the Purchased Shares.]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Each of the provisions of the Sales Agreement not specifically related to the solicitation by [BMO][RBC][BofA], as agent of the Company, of offers to purchase Shares
    in Agency Transactions is incorporated herein by reference in its entirety, and shall be deemed to be part of this Terms Agreement to the same extent as if such provisions had been set forth in full herein.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">An amendment to the Registration Statement, or a supplement to the Prospectus, as the case may be, relating to the Purchased Shares [and the Additional Shares], in the
    form heretofore delivered to [BMO][RBC] [BofA] is now proposed to be filed with the Securities and Exchange Commission.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Subject to the terms and conditions set forth herein and in the Schedule hereto and subject the terms and conditions of the Sales Agreement incorporated herein as
    provided in the second immediately preceding paragraph, the Company agrees to issue and sell to [BMO][RBC][BofA], and [BMO][RBC][BofA] agrees to purchase from the Company, the Purchased Shares at the time and place and at the purchase price set forth
    in the Schedule hereto.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">[<i>Remainder of Page Intentionally Blank</i>]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <!-- Field: Page; Sequence: 36; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If the fore<font style="font-family: Times New Roman, Times, Serif">going is in accordance with your understanding, please sign and return to us a counterpart hereof,
      whereupon this Terms Agreement, including those provisions of the Sales Agreement incorporated herein by reference, shall constitute a binding agreement between [BMO][RBC][BofA] and the Company.</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></p>
  <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

      <tr style="vertical-align: top">
        <td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">COEUR MINING, INC.</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
        <td colspan="2"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td style="width: 50%"><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
        <td style="width: 4%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
        <td style="border-bottom: Black 1pt solid; width: 46%"><font style="font-family: Times New Roman, Times, Serif">&#160;&#160;&#160;</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
        <td></td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</font></td>
      </tr>
      <tr style="vertical-align: top">
        <td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
        <td></td>
        <td><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</font></td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in"></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 276pt">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Accepted and agreed as of</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">the date first above written:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">[BMO Capital MarketS CORP.]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">[RBC Capital markets, llc]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">[BOFA SECURITIES, INC.]</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="text-transform: uppercase">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">
    <table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">

        <tr style="vertical-align: top">
          <td style="width: 4%"><font style="font-size: 10pt">By:</font></td>
          <td style="border-bottom: Black 1pt solid; width: 46%">&#160;</td>
          <td style="width: 50%">&#160;</td>
        </tr>
        <tr style="vertical-align: top">
          <td></td>
          <td><font style="font-family: Times New Roman, Times, Serif">Name:</font></td>
          <td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
        </tr>
        <tr style="vertical-align: top">
          <td></td>
          <td><font style="font-family: Times New Roman, Times, Serif">Title:</font></td>
          <td><font style="font-family: Times New Roman, Times, Serif">&#160;</font></td>
        </tr>

    </table>

  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><font style="font-family: Times New Roman, Times, Serif; text-transform: uppercase">&#160;</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
  <!-- Field: Page; Sequence: 37; Value: 2 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Schedule to Terms Agreement</b></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[Price to Public:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">USD[__.__] per share]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Purchase Price by [BMO][RBC][BofA]:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">USD[__.__] per share</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Method of and Specified Funds for Payment of Purchase Price:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">[By wire transfer to a bank account specified by the Company in same day funds.]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Method of Delivery:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">To [BMO&#8217;s][RBC&#8217;s][BofA&#8217;s] account, or the account of [BMO&#8217;s][RBC&#8217;s][BofA&#8217;s] designee, at The Depository Trust Company via DWAC in return for payment of the purchase price.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Settlement Date:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">[_______], 20[__]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Closing Location:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">[_______]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Documents to be Delivered:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following documents referred to in the Sales Agreement shall be delivered as a condition to the closing (which documents shall be dated on or as of the date of the Terms Agreement to
    which this Scheduled is annexed):</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"></td>
        <td style="width: 0.25in"><font style="font-family: Symbol">&#183;</font></td>
        <td>the officer&#8217;s certificate referred to in Section 4(c);</td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"></td>
        <td style="width: 0.25in"><font style="font-family: Symbol">&#183;</font></td>
        <td>the legal opinions referred to in Section 4(d) and (e);</td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"></td>
        <td style="width: 0.25in"><font style="font-family: Symbol">&#183;</font></td>
        <td>the &#8220;comfort letter&#8221; referred to in Section 4(f); and</td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>
  <table width="100%" cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">

      <tr style="vertical-align: top">
        <td style="width: 0.25in"></td>
        <td style="width: 0.25in"><font style="font-family: Symbol">&#183;</font></td>
        <td>such other documents as [BMO][RBC][BofA] shall reasonably request.</td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[Indemnity:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">[_______]]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">[Lockup:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition to, and without limiting the generality of, the covenant set forth in Section 3(q) of the Sales Agreement, [________].]</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
  <!-- Field: Page; Sequence: 38; Options: Last -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ny20009915x2_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions
         Document created using Broadridge PROfile 23.7.1.5162
         Copyright 1995 - 2023 Broadridge -->
  </head>
<body style="font: 10pt Times New Roman, Times, Serif">
  <p style="text-align: right; margin: 0"></p>
  <!-- Field: Rule-Page -->
  <div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%">
    <div style="font-size: 1pt; border-top: Black 4pt solid">&#160;</div>
  </div>
  <!-- Field: /Rule-Page -->
  <p style="margin: 0; text-align: right">&#160;</p>
  <p style="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right"><b>Exhibit 5.1</b></p>
  <p style="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right">&#160;</p>
  <table style="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%" cellpadding="0" cellspacing="0">

      <tr style="vertical-align: top; text-align: left">
        <td style="width: 37%;"><img src="ny20009915x2_ex5-1img01.jpg" alt="">&#160;</td>
        <td style="width: 42%">&#160;</td>
        <td style="white-space: nowrap; width: 21%">
          <p style="margin-top: 0; margin-bottom: 0;">Gibson, Dunn &amp; Crutcher LLP</p>
          <p style="margin-top: 0; margin-bottom: 0;">&#160;</p>
          <p style="margin-top: 0; margin-bottom: 0;">200 Park Avenue</p>
          <p style="margin-top: 0; margin-bottom: 0;">New York, NY 10166-0193</p>
          <p style="margin-top: 0; margin-bottom: 0;">Tel 212.351.4000</p>
          <p style="margin-top: 0; margin-bottom: 0;">www.gibsondunn.com</p>
        </td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>&#160;</td>
        <td style="white-space: nowrap">&#160;</td>
      </tr>
      <tr style="vertical-align: top; text-align: left">
        <td>&#160;</td>
        <td>&#160;</td>
        <td style="white-space: nowrap">Client: 19398-00108</td>
      </tr>

  </table>
  <p style="margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: right">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 10, 2023</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Coeur Mining, Inc.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">200 South Wacker Drive, Suite 2100</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Chicago, IL 60606</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <table style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" cellpadding="0" cellspacing="0">

      <tr style="vertical-align: top">
        <td style="width: 0%"></td>
        <td style="width: 0.5in">Re:</td>
        <td>
          <div>Coeur Mining, Inc.<br>
            Common Stock Offering</div>
          <div>
            <p style="font: 10pt Times New Roman,Times,serif; margin-top: 0pt; margin-bottom: 0pt;">Registration Statement on Form S-3 (File No. 333-262799)</p>
          </div>
        </td>
      </tr>

  </table>
  <p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Ladies and Gentlemen:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have examined the Registration Statement on
    Form S-3, File No. 333-262799 (the&#160;&#8220;<u>Registration&#160;&#160;&#160; Statement</u>&#8221;), &#160;&#160;&#160;of Coeur&#160;&#160;&#160; Mining,&#160;&#160;&#160;Inc.,&#160;&#160;&#160;&#160;a&#160;&#160;&#160;&#160;Delaware&#160;&#160;&#160;&#160;corporation (the&#160;&#8220;<u>Company</u>&#8221;),
    filed with the Securities and Exchange Commission (the&#160;&#8220;<u>Commission</u>&#8221;) pursuant to the Securities Act of 1933, as
    amended (the&#160;&#8220;<u>Securities Act</u>&#8221;), and the prospectus and prospectus supplement with respect thereto, dated February
    17, 2022 and August 10, 2023, respectively, in connection with the offering by the Company from time to time pursuant to Rule 415 under
    the Securities Act of shares of the Company&#8217;s common stock, par value $0.01 per share, having an aggregate offering price to the
    public of up to $50,000,000 (the&#160;&#8220;<u>Shares</u>&#8221;). The Shares will be issued pursuant to that certain ATM Equity Offering
    Sales Agreement dated as of August 10, 2023 (the&#160;&#8220;<u>Sales Agreement</u>&#8221;) among the Company and the sales agents named
    therein.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In arriving at the opinion expressed below, we
    have examined originals, or copies certified or otherwise identified to our satisfaction as being true and complete copies of the originals,
    of such documents, records, certificates of officers of the Company and of public officials and other instruments as we have deemed necessary
    or advisable to enable us to render this opinion. In our examination, we have assumed without independent investigation the genuineness
    of all signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals
    and the conformity to original documents of all documents submitted to us as copies.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based upon the foregoing, and subject to the assumptions,
    exceptions, qualifications and limitations set forth herein, we are of the opinion that, when the Shares have been issued and delivered
    in accordance with the Sales Agreement for the consideration provided for therein, such Shares will be validly issued, fully paid and
    non-assessable.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><font style="font-family: Times New Roman, Times, Serif">Abu Dhabi </font><font style="font-family: Wingdings 2">&#8211;</font>
    <font style="font-family: Times New Roman, Times, Serif">Beijing </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">Brussels
    </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">Century City </font><font style="font-family: Wingdings 2">&#8211;</font>
    <font style="font-family: Times New Roman, Times, Serif">Dallas </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">Denver
    </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">Dubai </font><font style="font-family: Wingdings 2">&#8211;</font>
    <font style="font-family: Times New Roman, Times, Serif">Frankfurt </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">Hong
      Kong </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">Houston </font><font style="font-family: Wingdings 2">&#8211;</font>
    <font style="font-family: Times New Roman, Times, Serif">London </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">Los
      Angeles<br>
      Munich </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">New York
    </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">Orange County </font><font style="font-family: Wingdings 2">&#8211;</font>
    <font style="font-family: Times New Roman, Times, Serif">Palo Alto </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">Paris
    </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">San Francisco </font><font style="font-family: Wingdings 2">&#8211;</font>
    <font style="font-family: Times New Roman, Times, Serif">Singapore </font><font style="font-family: Wingdings 2">&#8211;</font> <font style="font-family: Times New Roman, Times, Serif">Washington,
      D.C.</font></p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>
  <!-- Field: Page; Sequence: 1 -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
  </div>
  <div style="text-align: center; page-break-before: always; margin-top: 6pt; margin-bottom: 6pt">
    <p style="margin: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><img src="ny20009915x2_ex5-1img01.jpg" alt="">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Coeur Mining, Inc.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">August 10, 2023</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Page 2</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The opinion expressed above is subject to the
    following exceptions, qualifications, limitations and assumptions:</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <table style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" cellpadding="0" cellspacing="0">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.25in">A.</td>
        <td style="text-align: justify">The effectiveness of the Registration Statement under the Securities Act will not have been terminated
          or rescinded.</td>
      </tr>

  </table>
  <table style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" cellpadding="0" cellspacing="0" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 36pt"></td>
        <td style="width: 18pt">&#160;</td>
        <td style="text-align: justify"></td>
      </tr>

  </table>
  <table style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" cellpadding="0" cellspacing="0">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.25in">B.</td>
        <td style="text-align: justify">We render no opinion herein as to matters involving the laws of any jurisdiction other than the Delaware
          General Corporation Law (the&#160;&#8220;<u>DGCL</u>&#8221;). This opinion is limited to the effect of the current state of the DGCL and
          the facts as they currently exist. We assume no obligation to revise or supplement this opinion in the event of future changes in such
          laws or the interpretations thereof or such facts.</td>
      </tr>

  </table>
  <table style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" cellpadding="0" cellspacing="0" width="100%">

      <tr style="vertical-align: top">
        <td style="width: 36pt"></td>
        <td style="width: 18pt">&#160;</td>
        <td style="text-align: justify"></td>
      </tr>

  </table>
  <table style="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt" cellpadding="0" cellspacing="0">

      <tr style="vertical-align: top">
        <td style="width: 0.5in"></td>
        <td style="width: 0.25in">C.</td>
        <td style="text-align: justify">All offers and sales of the Shares will (i)&#160;comply with the minimum offering price limitation and
          (ii)&#160;be completed on or prior to the &#8220;ATM Offering Deadline,&#8221; each as set forth in the authorization of the offering
          and sale of the Shares by the Company&#8217;s Board of Directors.</td>
      </tr>

  </table>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We consent to the filing of this opinion as an
    exhibit to the Registration Statement, and we further consent to the use of our name under the caption &#8220;Legal Matters&#8221; in
    the Registration Statement and the prospectus that forms a part thereof. In giving these consents, we do not thereby admit that we are
    within the category of persons whose consent is required under Section&#160;7 of the Securities Act or the rules and regulations of the
    Commission promulgated thereunder.</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Very truly yours,</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">/s/ Gibson, Dunn &amp; Crutcher LLP</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>
  <p style="margin: 0"></p>
  <!-- Field: Page; Sequence: 2; Options: Last -->
  <div style="margin-top: 6pt; margin-bottom: 6pt; border-bottom: Black 2pt solid">
    <p style="text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>
  </div>
  <!-- Field: /Page -->
  <p style="margin: 0">&#160;</p>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>cde-20230810.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.7.1.5162 Broadridge-->
<xs:schema targetNamespace="http://coeur.com/20230810" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:cde="http://coeur.com/20230810" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="cde-20230810_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="cde-20230810_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://coeur.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>cde-20230810_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.7.1.5162 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>cde-20230810_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 23.7.1.5162 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://coeur.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="cde-20230810.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://coeur.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>ny20009915x2_ex5-1img01.jpg
<TEXT>
begin 644 ny20009915x2_ex5-1img01.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  K 00# 2(  A$! Q$!_\0
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M<)7JN7NGVWI?C#P=KZNVA^*_#>MA6,3'2-9TN_(E"@>43:W$FQSC;Y> W3
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MOE;UY=5?HE=,J4:-:<*E:E3K5*=U"I4A&<H)Z<L7*+LM/5[WN>4>&?@[\+/
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M=S75_/X#\)27M\[3W\[^&=":YO)VY:>[N'L'EN)6(+-),TC,3G)'3TS8OO\
M]]-SQCGGGU&<X.2.2332H# #.#N)&3C)=.V>G)P.@R< 5,*]52A556LZMVG5
ME5JJHXRE4:C>-1*T;VCI>T8MMM-F;P6"E1]A+!X9TO:*K[/V:Y.?2]X\MK.R
MZ7LK;'G,'PQ^'UC<"_LOAYX,MKZ-E>*[M?"GA^WNRPP-QN(M.CE#@E0K*P)
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MTL4?/E12.X&2,_-70S6AE,X9'\O8$4[@I<*0>,<*<IN1@05VY Y.=S:,@\Y
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HY);]6)/X=**UYG_)2^<7=]VWU;=VWW;.CVG]RGLE\-]DDOM=DC__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.2</span><table class="report" border="0" cellspacing="2" id="idm139781422745680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Aug. 10, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 10,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-8641<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Coeur Mining, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000215466<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-0109423<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">200 S. Wacker Dr.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 2100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Chicago<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">312<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">489-5800<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock (par value $.01 per share)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">CDE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>ny20009915x2_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="cde-20230810.xsd" xlink:type="simple"/>
    <context id="c20230810to20230810">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000215466</identifier>
        </entity>
        <period>
            <startDate>2023-08-10</startDate>
            <endDate>2023-08-10</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20230810to20230810"
      id="Fact_e6db019fd2d64d97b8bfc49b21e545df">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20230810to20230810"
      id="Fact_2b052ea68b63457686f924a8e48bac30">0000215466</dei:EntityCentralIndexKey>
    <dei:EntityAddressStateOrProvince
      contextRef="c20230810to20230810"
      id="Fact_9af5b99b7b1f4429bac9d9bd68173640">IL</dei:EntityAddressStateOrProvince>
    <dei:SecurityExchangeName
      contextRef="c20230810to20230810"
      id="Fact_7b510316653e4b78a46dfb8577bc842b">NYSE</dei:SecurityExchangeName>
    <dei:DocumentType
      contextRef="c20230810to20230810"
      id="Fact_a5038d14aba746a69227ec7c4fa533ca">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20230810to20230810"
      id="Fact_c05f01a1b8484fe1a2717d790a8a1919">2023-08-10</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20230810to20230810"
      id="Fact_74cb38877efc449e8780f6c38ec5cf14">Coeur Mining, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20230810to20230810"
      id="Fact_fbd0bc66b0724329b29d5cc8041e0df3">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20230810to20230810"
      id="Fact_514fee11664a4c62ba7e6f9a44b7511e">1-8641</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20230810to20230810"
      id="Fact_d8bf0e27240546b9b7227f1346c43e1a">82-0109423</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20230810to20230810"
      id="Fact_0506c8148dd64432b535746b66722451">200 S. Wacker Dr.</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20230810to20230810"
      id="Fact_8016f7cf98da4123a97ac0a13dd02201">Suite 2100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20230810to20230810"
      id="Fact_14537aa7d57a4bf48dc06b4f9c3e8700">Chicago</dei:EntityAddressCityOrTown>
    <dei:EntityAddressPostalZipCode
      contextRef="c20230810to20230810"
      id="Fact_56722a93eaf24425a1610648fdedbef6">60606</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20230810to20230810"
      id="Fact_f663b8e6f0e140d7b9b7b1a38b42ec85">312</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20230810to20230810"
      id="Fact_e2a16f29de8a4557be3a0781277fbc0d">489-5800</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20230810to20230810"
      id="Fact_cc2dc65aa9274ca1952419e9b13db0b3">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20230810to20230810"
      id="Fact_69be07e03ac14a1d9897bebe18af765f">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20230810to20230810"
      id="Fact_04074b7eb0e346b699d1231af3bbf1dd">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20230810to20230810"
      id="Fact_bf86179f659c40df93601320a1e43fd9">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20230810to20230810"
      id="Fact_8d3532629e774a63aafb91f15f1164aa">Common Stock (par value $.01 per share)</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20230810to20230810"
      id="Fact_e7c6fe8ec0e1495ca78feac2fde7fade">CDE</dei:TradingSymbol>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20230810to20230810"
      id="Fact_d0db397d7d794693a0d39de2c2afc40c">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M-_=%KLWC":[?#'!X=/X!4$L#!!0    ( "<Z"E=ED'F2&0$  ,\#   3
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M  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  G.@I7)!Z;HJT   #X 0
M&@              @ ',$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-0
M2P$"% ,4    "  G.@I799!YDAD!  #/ P  $P              @ &Q$@
I6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #[$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ny20009915x2_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://coeur.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 2 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityAddressStateOrProvince, dei:SecurityExchangeName -  ny20009915x2_8k.htm 11</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" original="ny20009915x2_8k.htm">ny20009915x2_8k.htm</File>
    <File>cde-20230810.xsd</File>
    <File>cde-20230810_lab.xml</File>
    <File>cde-20230810_pre.xml</File>
    <File>ny20009915x2_ex1-1.htm</File>
    <File>ny20009915x2_ex5-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ny20009915x2_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "ny20009915x2_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cde-20230810_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cde-20230810_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "cde-20230810.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    }
   },
   "elementCount": 29,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2023": 4,
    "total": 4
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "cde",
   "nsuri": "http://coeur.com/20230810",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ny20009915x2_8k.htm",
      "contextRef": "c20230810to20230810",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://coeur.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "ny20009915x2_8k.htm",
      "contextRef": "c20230810to20230810",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "presentation": [
      "http://coeur.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0001140361-23-038901-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-23-038901-xbrl.zip
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MK?F@-P/1E X*HZYD1R1#V80',LYA2,1(Y!F"6!-L.CW<GSGDA$8<&(PB4$,
M6OK8D)$S/$\(8]5S 074UQ?W78(.K.L?%I@"L'M$)AD@C>I;!4BJ+%+!W"+
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M-I4V!58IT_X(UK#2OJ1AE9OH L;K-,C1 791]_P.@2!-(/R+(^:WL+Y^$HD
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MA:=<5D*I5M9"@Q&84Z;NQXUX1.(WD44>G-DH3>==L*@.Q&SFL<\!;J7H?T7
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MEH'J1*<\R_CX]3*K>$;@FAP?5LXH"*^_D6G%:T$5X)+ 'SFK!+A_6<%#5SQ
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M6T%<M27O5CR=_%G#?W$!-<ELZ[38>5T[8=8C;97RT='U3<5< R*RF"@"!_@
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M"2]\P(>$V1)"M\/%+0GV&' NLH,5E5^:!#>#"8W7:9&)OM#""]!8EMA:?@1
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MIO_D T/WQS,AH="@NUN@TS$L1(.L*4JCRO9+U@[_<5UE[ZH27 'QKR#YG@
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MY KND6,@ T:4^8R$Q389T,V3!S?>N+Q#*.(#. QOWDTV/@RWA6_&NCVY2%0
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M;2"LU)\HWTD)XJ!0:Z%#3:\U,I$+0>KV2UI';GH;(5NW/.L^V\^[ R&^>_!
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MK2FULY1/DOF5.MB>,F74,1TY;U/YDS/JA[8C]]C&C O+A/JLN2;:_)TC*+A
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M8/@P0[<L'R%:K\H5KYBE?,6GZJMF@84O@VF^;A9LH.G9HZ\SRN*/Q,NATS9
MT(%M<+/$'$=#W*-K'IC=EQ:N.+?_NK?CY%/ 8TR9$*I?DP1=L$9)5A0XOR2(
M1^)_Q=2@=3CDOWSL0)X6?/>'P4C,TTS%*_9A6@63@MA\!74YC"F@">$J:#N
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M6:87-UA(G%W7DW<L9;3-.GX?=?QCC@NOA)OLXC:1$.AO2.4<XA F,10U0KP
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M(D$WY*H0)]AP+V1%MXI**^M#EBD7KVH@2@#M08+0RPG=-3 E6W*H(LZ$6%,
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M2D,ZEGN]R94'Q$EW3S#SI7E;7CTE?.^=M^4.M>DA*398PUL",)^]O\R0&+I
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M$&1/3&'C@3#L[.Q#J=N[D*Y;QUTH0,;L S=?V-%(I(6X#RDRL3^T^=)@[_Z
M/75V=IKMSN[6?4A^$@JR[[:VMCNM9["&^] :C\>MOE-% D6T8CVL4ZM9!B[,
MX8KL?*GEW<4D%]KQ3\SMB9+"0='NUNZ+9KO=:;]8QKH/" [A?AB>9K>-R)6
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MK)LG(YF[?2X6*U+W"6"%"T- :#"]S$MQM["]<Q+Q@G5@WYC.P>$[PX#D. V
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M7:=!7Y;A.)\*)7<5X$2[3:Q[&0;$DR&MGHCY\K#GA9PG6"EU5O2U<7T H4F
MC0=Z1I<BK1%?"UA;$I9^[CNIO-J?3\UVK@'*B\@4*O2K&=$O5 AC?HAGIM*^
M!@$,"]5W'4)N"6Z^59ZV5YX;^(^ ["Q6.6$36$C>^)F9W<PWV0V_>?.PL>+Z
M[[PM_6+@?!*TN\_>AUP ]JFY?< YT6^G'RNRJ5(YV*0O:;H/X4NH_P-02P$"
M% ,4    "  G.@I7LQ7A^C\#   M#P  $               @ $     8V1E
M+3(P,C,P.#$P+GAS9%!+ 0(4 Q0    ( "<Z"E>O#GX^?P@  '18   4
M          "  6T#  !C9&4M,C R,S X,3!?;&%B+GAM;%!+ 0(4 Q0    (
M "<Z"E=Q%ZB^V 4  .H^   4              "  1X,  !C9&4M,C R,S X
M,3!?<')E+GAM;%!+ 0(4 Q0    ( "<Z"E<@RP1 MA$  --8   3
M      "  2@2  !N>3(P,# Y.3$U>#)?.&LN:'1M4$L! A0#%     @ )SH*
M5XJXJ(;KJP  4> # !8              ( !#R0  &YY,C P,#DY,35X,E]E
M>#$M,2YH=&U02P$"% ,4    "  G.@I7TMV6 X$+  "-.@  %@
M    @ $NT   ;GDR,# P.3DQ-7@R7V5X-2TQ+FAT;5!+!08     !@ & (L!
(  #CVP     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
